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Abstract 
The report offers an analysis of the R&I system in the Czech Republic for 2014, including relevant policies and funding, 
with particular focus on topics critical for two EU policies: the European Research Area and the Innovation Union. The 
report was prepared according to a set of guidelines for collecting and analysing a range of materials, including policy 
documents, statistics, evaluation reports, websites etc. The report identifies the structural challenges of the Czech 
research and innovation system and assesses the match between the national priorities and those challenges, highlighting 
the latest policy developments, their dynamics and impact in the overall national context.   
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Executive summary 
 
The objective of the report is to provide an up-to-date overview of the R&D and innovation 
(RDI) system of the Czech Republic and to assess the evolution of national research and 
innovation policies in the perspective of the EUROPE 2020 Strategy. The main focus is on 
developments along the topics central to the EU policies of the European Research Area 
(ERA) and Innovation Union (IU), including the issues of governance, funding, transnational 
co-operation, labour market, framework conditions for innovation and market, transfer and 
circulation of knowledge. The report was prepared according to a set of guidelines for 
collecting and analysing a range of materials, such as policy documents, statistics and 
evaluation reports. 
Overall, the Reform of the Research, Development and Innovation (RDI) System launched in 
2008 and the consequent agenda of the National RDI Policy 2009-2015 are aligned with 
the EUROPE 2020 Strategy. A number of strategic documents that have been published 
during the reform highlighted the key problems and stimulated a much needed public 
debate; however, policy response and implementation have been piecemeal so far. The 
main success area is the upgrading of research infrastructures, while the progress has 
been slow in promoting excellence, opening the labour market, reforming the evaluation 
framework and getting ideas to market.  
Despite the economic crisis and major slowdown of economic growth, R&D intensity of the 
economy in terms of gross domestic expenditure on R&D (GERD) as % of GDP increased 
from the bottom of 1.24% in 2008 to 1.91% in 2013 (Eurostat, 2014). Since 2011 public 
funding slightly predominates over the private one. Business and foreign R&D funding, 
including from the EU Structural Funds, grew rapidly over the recent years, while national 
public funding of R&D tends to stagnate, which casts doubts about the sustainability of 
recent R&D investments growth. 
Governance coordination issues, the revision of evaluation methodologies and generally 
more efficient allocation of public research funding are flagged as the top policy priorities. 
Structure of the public RDI system was revised early in the reform. The Council for R&D 
and Innovation (CRDI) has become the central policy actor, the Technology Agency of the 
Czech Republic (TA CR) has been established and the funding flows have been streamlined. 
Nevertheless, the governance reform has slowed down significantly after the initial push 
and many of the changes remain half-baked due to disagreements among the main 
stakeholders, in particular over allocation of institutional funding. 
New research centres and infrastructure projects that have been constructed with 
subsidies from the EU Structural Funds represent a great promise for boosting the 
research output. According to preliminary estimates, however, their operating expenses 
may account for as much as one fifth to one third of the current public R&D budget. Unless 
the amount of public R&D outlays is significantly expanded, which is not expected in the 
medium-term outlook, public research organisations, including the newly build projects, 
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may end up being underfunded. National program sustainability I and II have been enacted 
to at least partly alleviate the lack of funds for the launch of the new facilities but how 
they are managed, staffed, and integrated into the system remains to be seen.  
One aim that has been repeatedly stressed in the policy documents is to increase the 
quality of human resources in research. Unfortunately, higher education reform ended up 
in doldrums. Despite initially ambitious plans, the reform agenda in this domain has been 
significantly watered down, as the result of which resolving the core problems, such as 
rigid recruitment practices, are not under consideration anymore. Horizontal mobility of 
academic staff is low, competition for posts weak and inbreeding widespread. Gender 
inequality issues are not systematically tackled. Research internationalization is very 
limited in the public sector. Much remains to be done in improving the labour market for 
researchers. 
Given the historical separation of science and business, improving public-private circulation, 
collaboration and transfer of scientific knowledge is a constant policy challenge. New 
measures were introduced that are shifting the focus of public subsidies to promoting joint 
public-private projects. Another major policy shift is from a support system to innovation 
traditionally based on direct subsidies to firms towards a wider portfolio of measures, 
including tax credits, loan guarantees and provision of support services. But many public-
private linkages are informal, technology transfer services are weak and the absorptive 
capacity of firms is insufficient. Governance of public-private collaboration in research 
institutions remains underdeveloped. 
A major policy shift has been from a system traditionally focused on science towards more 
attention devoted to boosting innovation. But the success has been at best partial so far. 
Structurally, the business sector appears sound; the high- and medium-high-technology 
sector is large. However, there is a lingering gap in innovation performance, as the 
business sector is specialized in low value added segments of value chains. Foreign 
affiliates are poorly integrated in the national innovation system, access to venture capital 
is limited and path-breaking innovation is rare. Innovation activities performed by 
enterprises are focused on the absorption of technologies new to the firm and 
experimental development rather than research. 
Generally speaking, the policy mix aims to tackle the main challenges. For the first time, 
the strategic reform documents that were released from 2008 onwards outlined the RDI 
policy in a coherent, manner and there seems to be emerging consensus on the way 
forward. In recent years, the Czech RDI system embarked on a catching up trajectory with 
advanced European countries. Yet many IU indicators have not reached the EU28 average 
and the lag behind innovation leaders remains quite significant. No doubt progress has 
been made, but in many respects the progress towards meeting the ERA’s objectives and 
IU commitments has been painstakingly slow and a number of the objectives outlined in 
the National RDI Policy 2009-2015 and its mid-term update from 2013 are not likely to be 
satisfactorily achieved. 
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1. Overview of the R&I system 
1.1 Czech Republic in the European RDI landscape 
The Czech Republic is a medium size Central European country with an area of 78.9 
thousands square kilometres and population of 10.5 million people, accounting for, 
respectively, 1.8% and 2.1% of the EU28 total. In 2013, gross domestic product (GDP) per 
capita in purchasing power standards reached €20,600, 80% of the EU28 average. After 
real GDP dropped in the peak of the crisis by 4.5% in 2009, the economy slowly recovered 
by 2.5% in 2010 and 1.8% and 2011; however, this positive trend did not last and the GDP 
dropped by 1.0% in 2012 and 0.9% in 2013 (Eurostat, 2014). 
 
1.2 Main features of the R&I system 
Despite the sluggish economy, gross domestic expenditure on R&D (GERD) as % of GDP 
increased from the crisis bottom of 1.24 % in 2008 to 1.91% in 2013, getting significantly 
closer to the EU28 average of 2.02%. In 2013, the business sector financed 38% of GERD, 
of which 97% was spent by the firms themselves testifying to their weak link to the rest of 
the system. Business expenditure on R&D (BERD) as % of GDP expanded to 1.03% in 2013 
compared to 0.96% in 2012 and 0.86% in 2011, hence catching-up with the EU28 average 
of 1.29%. In 2013, the government sector financed 35% and foreign sources – a 
combination of EU Structural Funds and foreign business funds - accounted for as much as 
27% of GERD going up from only 9% in 2008, which makes the latter by far the most 
dynamic source (Eurostat, 2014). 
On one hand, there is clearly a catching up trend in research productivity with the EU28 
average. On the other hand, however, the research and innovation system as a whole still 
lags behind the EU28 average in terms of research outputs per capita or per GDP 
(European Commission, 2014a).As far as high-quality R&D outputs, such as internationally 
recognized scientific publications and triadic patents, are concerned, there are several high-
profile fields that stand out, including organic chemistry, nuclear physics, medical sciences, 
textile materials, machine tools, electrical engineering, combustion engines and vehicles in 
general.  
 
1.3 Structure of the national research and innovation system 
and its governance 
At the heart of the public research sector is (i) the Academy of Sciences of the Czech 
Republic (ASCR), consisting of 54 formally independent public research institutes, and (ii) 
26 public, 2 state and 44 private higher education institutions. Unlike in Western Europe, a 
large part of research activities are under the umbrella of the ASCR, the primary mission of 
which is to conduct basic research, while the higher education sector has been traditionally 
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less research-oriented and more focused on teaching. Nevertheless, this has been 
changing in recent years, as the ASCR tends to get more involved in applied research and 
the higher education sector significantly expands its research activities. 
The private research sector consists of about 2,300 actors that perform R&D activities, of 
which about 25% are foreign affiliates and 80% are small and medium size enterprises. 
The main R&D performing sectors are the automotive, machinery, electronics and 
information and communication industries with about 50% share in both R&D employment 
and expenditure, respectively (CZSO, 2014a). By far the largest single private R&D 
performer is well-known to be the carmaker Škoda Auto, a part of the Volkswagen Group, 
which maintains a large research facility and its own private university. Other major 
business R&D performers include, for example, Bosh, Honeywell, Škoda Transportation, 
Visteon-Autopal and Zentiva. Private research institutes that are specialized in applied 
research are organized under the umbrella of Association of Research Organizations (AVO), 
which has about 80 members. Association of Innovative Entrepreneurship (AIE) consists of 
30 organizations representing about 84,000 self-employed persons and 1,100 
corporations.   
In 2008, the Reform of the Research, Development and Innovation (RDI) system was 
launched. The reform profoundly changed the governance of RDI policy. Competences of 
particular governmental bodies are given by the Act No. 130/2002 Coll. on the Support of 
Research and Development from Public Funds and by the Reform amendment Act. no 
211/2009 Coll. The main players in RDI policy making are as follows: 
 
 Deputy Prime Minister for the Science, Research and Innovation is a member of the 
government responsible for RDI policy supported by the Section for Science, 
Research and Innovation at the Office of the Government. 
 Council for Research, Development and Innovation (CRDI) is an advisory government 
body for RDI policy with 17 members chaired by the Deputy Prime Minister for the 
Science, Research and Innovation. At the political level, the CRDI plays the main 
strategic and coordinating role.  
 Ministry of Education, Youth and Sports (MEYS) is the central administrative 
authority for R&D programmes in the public sector, particularly institutional funding 
for public universities, and for promoting international research collaboration. MEYS 
coordinates the EU Structural Funds through the Operational Programme Research 
and Development for Innovation (OP RDI) and the Operational Programme 
Education for Competitiveness (OP EC). 
 Ministry of Industry and Trade (MIT) administers policies in the domain of business 
RDI. MIT coordinates the EU Structural Funds through Operational Programme 
Enterprise and Innovation (OP EI). 
 Technology Agency of the Czech Republic (TA CR) provides competitive funding for 
applied research, experimental development and innovation. 
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 Czech Science Foundation (GA CR) provides funding for competitive grants in basic 
research. 
 Academy of Sciences of the Czech Republic (ASCR) is a major funding provider and 
as the whole the single most important research performer. 
 
Figure 1. Czech RDI governance system 
 
 
RDI policy making is fairly centralized. Regional authorities, the self-governing regions at 
the NUTS3 level, do not have any legally binding responsibilities in this respect. At the 
regional level, the role of RDI policy is limited to the implementation of national 
programmes and the implementation of regional development policies. Nonetheless, the 
law does not prevent the regional authorities from launching their own RDI policy 
initiatives, though only a very few have done so. 
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Main changes in 2014 
The National RIS Strategy was released. 
Nine out of sixteen members of the CRDI council were replaced. 
Pavel Bělobrádek was appointed the Deputy Prime Minister for the Science, Research and Innovation and the 
Chairman of the CRDI. 
The MEYS signed under the IPN METODIKA project a contract with Technopolis Group to design a new system 
of evaluation of research organisations and allocation of institutional funding. 
TA CR started funding the GAMA and DELTA programmes and announced the EPSILON programme. 
MIT shut down the project Seed Fund to launch a public-private venture capital fund. 
GA CR did not issue a new call for postdoc projects but started a new programme of junior projects. 
R&D tax credits were extended to purchase of external R&D services from research organisations. 
Main Changes in 2013 
Update of the National Research, Development and Innovation Policy 2009-2015 with an outlook to 2020 
re-confirmed the reform track. 
Metodika 2013 provided a medium-term modification of the formulae-base evaluation of research 
organisations and allocation of institutional funding. 
Higher education reform ended up in doldrums. 
The centre-right coalition government collapsed, early elections were held, and a new centre-left government 
was formed. 
National programs sustainability I. and the prospective National program sustainability II. were put in place to 
sustain financing of the new research centres and infrastructures. 
Main changes in 2012 
National Priorities of Oriented Research, Experimental Development and Innovation started to guide the 
design of new support programmes. 
The number of R&D budget providers was halved to 11 in the multi-annual budget plan. 
TA CR starts funding BETA, OMEGA and Competence Centres programmes. 
The TIP programme of the MIT was defunded in medium-term. 
Regional governments started to implement innovation voucher programmes. 
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Main changes in 2011 
Strategy of International Competitiveness addressed framework conditions affecting innovation performance. 
National Innovation Strategy outlined goals for innovation policy. 
TA CR starts funding projects in the first programme ALFA. 
Main Changes in 2010 
The Roadmap for Large Research, Development and Innovation Infrastructures in the Czech Republic paved 
the way for their construction. 
A new centre-right coalition government took office after regular parliamentary elections. 
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1. Recent Developments in Research and Innovation Policy 
and systems 
2.1 National economic and political context 
Real GDP growth was high for nearly a decade, annually on average about 4.5% over 
2000-2008, which was well above the EU28 average. However, the slump in export 
demand during the global economic crisis hit the economy hard and GDP dropped by 4.5% 
in 2009; despite the fact that the domestic financial sector did not face major difficulties 
thanks to the clean-up about a decade ago. In 2010 and 2011, the economy recovered at 
a slow pace with GDP growing by 2.5% and 1.8%, respectively, however only to plunge into 
a double dip recession with GDP declining by 1.0% in 2012 and by 0.9% in 2013 (Eurostat, 
2014).  
The center-right coalition government collapsed in June 2013. Early elections took place in 
October 2013 and a new centre-left coalition government is in place since early 2014. 
Pavel Bělobrádek, leader of the junior coalition partner the Christian Democratic Union – 
Czechoslovak People’s Party, has been appointed the Deputy Prime Minister for the 
Science, Research and Innovation, a newly created position in the RDI governance system, 
and the Chairman of the CRDI. Over the summer 2014, nine out of sixteen members of the 
CRDI council have been replaced, hence significantly changing the composition of the main 
policy body. So far there has not been a major shift in RDI policies. 
Pavel Bělobrádek, the Deputy Prime Minister for the Science, Research and Innovation, has 
been allocated about €4m in the public RDI budget in 2015 to build a new section under 
the Office of the Government, which ultimately may form the basis of an Office for 
Science, Research and Innovation and even a full-fledged Ministry of Science, Research and 
Innovation. A “big” novella of the Act No. 130/2002, on Support for Research, Experimental 
Research and Innovation is accordingly under preparation at the new department that 
besides other issues should clarify its status and that hence has the potential to 
fundamentally reform governance of the RDI system.  
 
2.2 National R&I strategies and policies 
The main priorities in the area of science, research and innovation as outlined in the Policy 
Statement of The Government of The Czech Republic that took office early in 2014 are to: 
i) Increase motivation within the private and public sectors to use RDI results; ii) Revise 
evaluation and funding of research institutions and projects to reflect their real 
contribution to the development of the Czech Republic; iii) Improve the functioning of the 
CRDI, promote mobility of RDI staff and PhD students and strengthen doctoral disciplines in 
applied fields; iv) Increase support for involvement in international projects, applied 
research, technology transfer and the use of venture capital; v) Support new growth 
sectors of the digital economy, cultural and creative industries; vi)  Formulate new 
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incentives to stimulate projects with high added value, high proportion of R&D and 
strategic services; and vii) Submit proposed amendments of higher-education legislation.  
The CRDI implements a medium term modification of the evaluation methodology of 
research outputs for the period 2013-2015, the so-called Metodika 2013 (CRDI, 2013b), 
on the base of which institutional funding is supposed to be allocated until 2016. Pillar I 
remains the same as before using formulae-based procedure of assigning points to 
publications. Pillar II newly involves international peer review of a list of top outputs 
submitted by the evaluated organisations, on the base of which the expert panel decides 
on distribution of a small amount of additional funding. Moreover, extra bonuses are 
awarded to research organisations, which obtained project funding from the ERC. Pillar III 
considers outputs of applied research, predominantly patents, and takes into account 
external funding acquired for applied research and contractual research. The formulae-
based allocation of points for outputs recorded in the previous five years continues to be 
the dominant part of the evaluation. A major departure from the previous funding 
mechanism, however, is that results of the evaluation provide only background information 
for budget decisions; hence institutional funding is not supposed to be automatically 
allocated based on evaluation. Partial results of Metodika 2013 were announced in 
January 2015 and the full report should be released in the first half of 2015 in order to be 
used for drafting 2016 budget recommendations. 
As the result of the implementation of the Reform of the RDI System, the number of R&D 
budget providers has been halved to 11 in the budget period 2013-2015. The 
responsibility for administrating national public support for applied research, experimental 
development and innovation was moved under the umbrella of the TA CR, which gradually 
takes over from ministries and other state institutions. On one hand, the budget of the TA 
CR grows, while the national R&D budget earmarked for competitive funding in the 
respective areas of ministries declines. On the other hand, the MEYS and MIT administer 
large Operational Programmes (OP) of the EU Structural Funds dealing with R&D and 
innovation; there is significant dynamics of expenditure within these programmes as 
national public co-financing is required. 
Since 2012, TA CR has started to fund a portfolio of new programmes: i) ALFA supports 
applied research and experimental development and stimulates public-private R&D 
cooperation with a budget of about €290m over the period 2011-2016; ii) BETA is a 
programme of public procurement in research, experimental development and innovation 
for the needs of public administration bodies with a budget of €25m over the period 
2012-2016; iii) OMEGA supports applied social science research and experimental 
development with a budget of €12 million over the period 2012-2017; and iv) Competence 
Centres supports projects of RDI centres in progressive fields with strong application 
potential and with conditions for the development of long-term collaboration between the 
public and private sectors, approximately 35 centres are supported with a budget of about 
€240m over 2012-2019, 28% of which has been already allocated to the recipients. 
Furthermore, TA CR started two additional programmes in 2014, namely i) GAMA 
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supporting the verification of R&D results in terms of their practical application and their 
subsequent commercial use with a budget of €69m over the period 2014 to 2019, and ii) 
DELTA funding grants for joint international projects with third countries with a budget of 
€30m over the period 2014-2019. TA CR also starts a new EPSILON programme in 2015, a 
follow-up on ALFA, which should last for 11 years until 2025 with a budget allocation of 
€373m, and which is aimed at supporting applied research and experimental development 
with a high potential for rapid application in innovations in the priority areas of i) 
Competitive knowledge-based economy; ii) Sustainability of energy and material resources; 
and iii) Environment for quality of life. 
GA CR continues to administer project-based funding of basic research with an annual 
budget of about €130m in 2014, which is earmarked to growth steadily to €150m in 
2017. The main funding instrument is a standard grant project, to which are allocated 
nearly three-quarters of the budget thus about €97m in 2014, the call for which is 
announced annually and which can have duration of 1-3 years. Other funding instruments 
with much smaller budget allocations include projects for excellence in basic research, 
postdoctoral grants, junior grants and international bilateral grants. 
New research centres and infrastructure projects financed by the OP RDI, through the 
Priority Axes 1 and 2 that are going to have a profound impact of the whole R&D system 
are under construction and gradually opening (MEYS, 2013). Six large projects with a total 
amount of subsidy of €835m (85% funded by the ERDF) were approved for funding in 
regions outside of the capital city of Prague in 2010: i) ELI - Extreme Light Infrastructure 
(€271m); ii) BIOCEV - Biotechnology and Biomedicine Research Centre (€92m); iii) CEITEC - 
Central European Institute of Technology (€209m); iv) Centrum excellence IT4Innovations 
(€72m); v) ICRC - International Clinical Research Center (€94m); and vi) SUSEN - Udrzitelna 
energetika (€97m). In addition, CIIRC - Czech Institute of Informatics, Robotics and 
Cybernetics (€54m) located in Prague was approved for funding in 2013. National 
programs sustainability I and II have been established to fund launching of the new 
facilities until 2020. 
Thematic funding programmes are underdeveloped and the thematic focus is not very 
strongly promoted by the existing funding sources. Hence, the share of public resources 
spent on thematically non-oriented research far exceeds expenditures on oriented 
research. According to the shares of socio-economic objectives (NABS), non-oriented 
research financed from general university funds had 28.3% and from other sources 29.9% 
share in GBAORD in 2012, respectively. Within thematically oriented research, representing 
the remaining 41.8% of GBAORD, industrial research prevails (15.9%), followed by medical 
research (6.2%) and transport, telecommunication and other infrastructure (4.2%). Other 
socio-economic objectives have a combined share of 15.5% on the total GBAORD 
(Eurostat, 2014).  
Despite the Reform of the RDI system, the balance between thematic and generic funding 
has remained remarkably stable; oscillating in a narrow range between 58% and 61% 
share of generic funds in GBAORD over the period 2008-2012. So far the allocation of 
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thematic funding has only loosely reflected the national priorities and grand challenges. 
Yet this is planned to change with implementation of the updated priorities of oriented 
R&D for the period until 2030 (CRDI, 2012), which are designed to reflect major societal 
challenges in line with in the Horizon 2020, and which should be respected in the thematic 
focus of new support programmes and prospectively also in allocation of institutional 
funding. None of the existing policy documents, however, sets binding targets in this 
respect. 
In July 2014, the government approved new operational programmes dealing with RDI that 
are going to be funded from the European Structural and Investment Funds (ESIF) during 
the programming period 2014-2020. The OP Enterprise and Innovation for 
Competitiveness (OP PIK) under the MIT with the EU contribution of €4.32b (a total budget 
allocation of €7.91b) is designed to support the development of a competitive and 
sustainable knowledge and innovation—based economy. The OP Research, Development 
and Education (OP VVV) administered by the MEYS with the EU contribution of €2.78b (a 
total budget allocation of €3.4b) is aimed to support the transition to economy based on 
education, motivated and creative labour force, high-quality research results and their 
implementation in practice. The Operational Programme Prague – Growth Pole of the Czech 
Republic (OP PGP) administered by the Prague City Hall with the EU contribution of €0.2b 
(a total budget allocation of €0.4b) includes one priority axis directly relevant to RDI on 
“Strengthening research, technological development and innovation” that is aimed at 
promoting public-private cooperation and the establishment and development of 
knowledge-intensive companies. It is expected that the OPs will be approved by the 
European Commission in the first half of 2015.  
Overall, the policy measures follow the National RDI Policy 2009-2015 and its mid-term 
update from 2013; hence in a broad sense they jointly form a coherent and integrated 
framework for reforming the RDI system that is in line with the EU priorities and 
increasingly aimed at promoting excellence in research and fostering innovation. However, 
the degree of implementation of the reform agenda is highly uneven and often falls short 
of expectations. Stakeholders are fragmented into adversary interest groups, along the 
dividing lines of industry, university and government sectors, rather than working in 
concert. Opportunities for joint programming are seldom exploited, cross-border 
cooperation remains rare and the leverage effect of EU funding largely depends on how 
the challenge of integrating the new research centres and infrastructures is tackled. New 
long-term priorities of oriented RDI announced in 2012 that are largely in line with the 
grand challenges of Horizon 2020 are increasingly accommodated in the design of new 
programmes of targeted support. The National RIS Strategy was released at the end of 
2014 and it remains to be seen to which extent it is going to be reflected in funding flows. 
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2.3 National Reform Programmes 2013 and 2014 
The national 2020 target is to reach 1% of public R&D expenditure per GDP. In 2013, 
government sector R&D funding obtained from national sources reached 0.66% of GDP, 
whereas public R&D funding from abroad, primarily from the EU Structural Funds, 
amounted to 0.31% of GDP, which in total is 0.97% of GDP (Eurostat, 2014). Hence, the 
national 2020 goal has been almost met, if the foreign public sources are included. 
However, this is to a large extent due to a spike of EU funding for the construction of 
several major projects of research infrastructure. It remains to be seen whether the 
increased level of public R&D funding will be sustained after the investment phase of 
these large-scale investment projects fizzles out.  
National Reform Programmes 2013 and 2014 stipulate that a new system of evaluation 
of research organisations and distribution of institutional funding is put in place (Office of 
the Government of the Czech Republic, 2013 and 2014a). IPN METODIKA project on 
“Efficient system of evaluation and financing of research, development and innovation” (as 
a part of the OP RDI under the auspice of MEYS), which is intended to conduct an in-depth 
revision of the methodology, is in progress, as a part of which in mid-2014 a consortium 
led by the Technopolis Group has been awarded a contract to produce the new 
methodology by mid-2015. After several years of a stalemate there seems to be an 
important policy shift, which is likely to lead into incorporating international best practices, 
including peer review, into the evaluation methodology. Nevertheless, no clear roadmap for 
implementation of the new methodology has been announced so far and it is expected 
that funding decisions could be based on results of the new methodology at the earliest in 
2017. 
Moreover, the National Reform Programme 2014 (Office of the Government of the Czech 
Republic, 2014a) recommends designing a new methodology of evaluation of targeted RDI 
support programmes, which includes ex-ante, interim and ex-post stages, and which 
involves the assessment of the intervention logic and evaluation of their effectiveness, 
results and impacts. In spring 2014, a working group consisting of the main providers of 
targeted funding started to work out the solution under the auspice of the CRDI. The 
working group is expected to outline systemic changes in the evaluation procedures of 
targeted support that are needed for achieving more efficient allocation of public funding. 
The memorandum produced by this working group is expected to be submitted to the 
government in spring 2015. 
Finally, as required in the third specific recommendation of the National Reform 
Programme 2014 (Office of the Government of the Czech Republic, 2014a) with RDI 
relevance, the government shall prepare a methodology for evaluating large RDI 
infrastructures. In this regard, a comprehensive two-stage assessment of all existing and 
planned projects of large R&D infrastructures carried out by the MEYS in the second half of 
2014. The evaluation was based on information submitted by research organisations, 
which registered their projects on a voluntary basis. In total, 119 projects have been 
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assessed and out of that 58 successfully passed the evaluation. The outcome of the 
evaluation will feed into the update of National Roadmap for Large Research, Experimental 
Development and Innovation Infrastructures that is going to be completed in 2015.. 
National Reform Programme 2013 (Office of the Government of the Czech Republic, 2013) 
further includes a range of recommendations that have been already addressed with 
various degrees of success. New priorities of oriented RDI are being reflected in the design 
of new programmes of targeted support (see Section 5.3). National Sustainability 
Programmes I and II aimed to fund operation of the new research centres and 
infrastructures are ready (see Section 5.3). New instruments stimulating business RDI as 
well as public-private cooperation have been launched most prominently under TA CR (see 
Sections 2.5, 4.4 and 5.3). New efforts have been started to upgrade technology transfer 
infrastructure (see Section 4.3). The National RIS Strategy has been published at the end of 
2014 (see Section 2.6). Unfortunately, the launch of a public-private seed fund has been 
terminated due to an appeal to the Office for the Protection of Competition (see Section 
4.6), however, there are plans to re-launch this effort in the new programming period. 
Foresight activities are developed under the MIT, TA CR and the Technology Centre of the 
ASCR. 
 
2.4 Policy developments related to Council Country Specific 
Recommendations 
The European Commission (2013b, 2014b) recommended introducing a new methodology 
for evaluating research and increasing the share of performance-based funding of 
research institutions. A revised methodology of evaluation of research organisations that is 
fully performance-based has been put in place for years 2013–2015 (for more details see 
Section 2.3), on the base of which institutional funding should be allocated until 2016. The 
revised methodology at least partly removes the highly criticized shortcomings of the 
previous evaluation system, though; the evaluation continues to heavily rely on the 
formulae-based approach. Contrary to the previous methodologies, however, it does not 
include explicit rules for allocating the institutional support, as the evaluation results only 
provide background information, which the CRDI is going to use for the preparation of its 
draft state budget for the RDI area. Hence, the evaluation system is based on performance 
indicators but institutional funding is distributed according to budget negotiations among 
actors. After 2015 a new system of RDI evaluation and distribution of institutional funding 
that is under preparation within the IPN METODIKA project by Technopolis Group (for more 
details also see Section 2.3) is scheduled to be gradually implemented; however, a 
roadmap has not been announced yet. 
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2.5 Funding trends 
2.5.1 Funding flows 
In 2013, gross domestic expenditure on R&D (GERD) amounted to €3.0b (CZK 78b) and 
increased by about 8% as compared to the previous year, driven mainly by the expansion 
of business and foreign funding, while national public funding stagnated. GERD jumped by 
56% over the period 2008-2013, which marks a remarkable recovery. As a consequence, 
R&D intensity of the economy in terms of GERD as % of GDP increased to 1.91% in 2013, 
as compared to the lowest point of 1.24 % at the dawn of the crisis in 2008, hence 
noticeably approaching the EU28 average of 2.02%. The national 2020 target of 1% public 
R&D intensity of GDP has been almost reached already, if foreign public sources are 
factored in, however, national public sources tend to stagnate, which casts doubts about 
sustainability of the recent R&D investments growth (Eurostat, 2014). 
Business enterprise expenditure on R&D (BERD) accounted for 54% (€1.62b) of the total, 
the higher education sector came second with 27% (€0.82b) closely followed by the public 
research institutions with 18% (€0.55b), while the private non-profit sector remained 
negligible accounting for less than 1% (€0.01b) in 2013. BERD as % of GDP reached 
1.03% in 2013, which represents a significant increase compared to 0.86% in 2011, the 
crisis bottom of 0.73% in 2008, and about 0.70% ten years ago. BERD is characterised by 
a level of domination by foreign-owned companies that is one of the highest in the EU, as 
about 55% was performed by foreign affiliates in 2013 up from 51% in 2011 but down 
from 57% in 2008; this represents a particular challenge for the design of RDI policies 
(Eurostat, 2014 and CZSO, 2014a). 
In 2013, the business sector financed 38% (€1.13b) of GERD, of which 97% was spend by 
the firms themselves, which testifies to the very weak link between the business sector 
and other parts of the system. About two-thirds of BERD continues to be financed from 
within the business enterprise sector, however, the share of BERD funded from abroad 
more than doubled from 10% in 2008 to 21% in 2013, driven predominantly by foreign 
business funding from members of the same group. The government sector funded 35% 
of GERD (€1.04b), most of which is split between higher education (47%) and public 
research institutions (35%). Foreign sources in total contributed by 27% (€0.81b) of GERD 
funding in 2013, tripling from only 9% in 2008. About 40% of the foreign funds came 
from private and 60% from public sources in 2012 and 2013; predominantly the EU funds, 
which is a major shift as the private segment dominated with more than 70% share before 
2011; this casts doubts on the sustainability of this increase (Eurostat, 2014 and CZSO, 
2014a). 
The role of the EU Structural Funds in the funding of R&D has grown enormously in the 
programming period 2007-2013. Public R&D activities were financed particularly by two 
OPs administered by the MEYS: OP RDI (ERDF) and OP EC (ESF). The combined allocation of 
these two OPs equalled approximately €3.8b. Business R&D and innovation activities were 
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financed through the OP EI administered by the MIT with a total budget of approximately 
€3b for RDI relevant activities. Innovation activities with only a small fraction of possible 
R&D financing were also supported by the OP Prague -Competitiveness (OP PC) and OP 
Prague – Adaptability (OP PA). Czech participants active in projects funded under the 7th 
Framework Programme acquired from the EU support of €289m in 1,146 projects, which 
represents a sizeable increase as compared to the 6th Framework Programme with the EU 
support of €139m in 890 projects. 
The government budgetary appropriations or outlays for R&D (GBAORD) amounted to 
€1.00b (CZK 26b) and the intensity of the economy in terms of GBAORD as % of GDP 
reached 0.67% in 2013, which represents a noticeable increase from €0.82b (CZK 20b) 
and 0.53% of GDP in 2008, respectively; however, the rise is largely due to the need to co-
finance the EU Structural Funds.  As the result, GBAORD as % of GDP nearly eliminated the 
gap as compared to the EU28 average of 0.69%, despite major cuts in other parts of the 
government budget during the prolonged recession (Eurostat, 2014). GBAORD stagnated 
roughly at the same level in 2013 and 2014 (CRDI, 2014) and are earmarked to slightly 
increase to €1.04b in the state budget approved by the parliament in 2015. 
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Table 1: Basic indicators for R&D investments 
 2009 2010 2011 2012 2013 EU28 
(2013) 
GDP growth rate -4.5 2.5 1.8 -1.0 -0.9 0.1 
GERD (% of GDP) 1.30 1.34 1.56 1.79 1.91 2.02 
GERD (euro per capita) 184.6 200.3 243.4 273.9 285.0 539.2 
GBAORD - Total R&D appropriations (€ million) 870 894 1,048 1,040 1,005 90 506 
R&D  funded by Business Enterprise Sector (% 
of GDP) 
0.52 0.55 0.59 0.65 0.72 1.10 
(2012) 
R&D funded by Private non-profit (% of GDP) 0.00 0.00 0.00 0.00 0.00 0.03 
(2012) 
R&D funded from abroad (% of GDP) 0.15 0.19 0.31 0.46 0.52 0.20 
(2012) 
R&D performed by HEIs  (% of GERD) 19.7 20.0 24.4 27.5 27.2 23.6. 
(2012) 
R&D performed by Government Sector (% of 
GERD) 
23.3 21.7 19.8 18.4 18.3 12.2 
(2012) 
R&D performed by Business Enterprise Sector 
(% of GERD) 
56.5 57.7 55.3 53.6 54.1 63.3 
(2012) 
Share of competitive vs. institutional public 
funding for R&D (in %) 
44.2 46.5 48.1 49.1 51.5 .. 
Employment in high- and medium-high-
technology manufacturing sectors (% of total 
employment) 
9.5 9.5 10.3 10.5 10.8 5.6 
 
Employment in knowledge-intensive service 
sectors (% of total employment) 
30.8 31.8 31.5 32.0 32.8 39.2 
Turnover from Innovation (% of total turnover) .. 15.3 .. .. .. 13.4 
(EU-
27, 
2010) 
Data sources: EUROSTAT 
 
2.5.2 Project vs. institutional allocation of public funding 
The public R&D funding has been traditionally dominated by institutional support. However, 
this is changing in the context of the Reform of the RDI System that has been launched in 
2008. As a result, according to the official classification used in GBAORD the share of 
project funds increased markedly in the last few years, namely from 44% in 2009 to 51% 
in 2014. The GBAORD multi-annual budget plan approved by the government in June 2014 
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outlines that the share of project funding will oscillate in the narrow range between 51% in 
2015, 52% in 2016 and 50% in 2017 (CRDI, 2014). However, in fact the true share of 
project funding is higher, probably in the range between 55% and 60% over 2014-2017, 
because several items officially recorded under the heading of institutional funding, such 
as co-financing of the EU Structural Funds administered by the MEYS and MIT or support to 
projects of international cooperation under the MEYS, do not necessarily meet the 
definition.  
Early in the reform a new methodology for evaluation of R&D results and distribution of 
institutional funding was introduced. The methodology was based exclusively on 
quantitative indicators. It has been decided that each provider receives institutional funds 
based on historical research results achieved over the past five years, as reported to the 
central database of research results. However, the new system has been heavily criticized 
by the academic community among other things for being too mechanistic, for not taking 
into account differences in publication behaviour between fields of science and for creating 
unstable funding conditions. In turn, the International Audit of Czech RDI concluded that the 
evaluation methodology is not fir for purpose and recommended a fundamental revision 
(Arnold, 2011). 
A medium term modification of the evaluation methodology has been introduced for the 
period 2013-2015, so-called Metodika 2013 (CRDI, 2013b), on the base of which 
institutional funding is going to be allocated until 2016. The new formulae are based on 
the compromise between the need to use quantitative criteria and other considerations by 
the main stakeholders (for more details see Section 2.2). According to the initial reform 
plans, almost the full amount of institutional funding was supposed to be allocated using 
the performance-based formulae. However, in order to stabilize the funding flows, a 
consensus has been reached that only 20% of the money is allocated using the evaluation 
results, hence competitively, while 80% of the money is divided in the same proportion as 
in the previous year, hence representing block funding. After 2015 a new system of RDI 
evaluation and distribution of institutional funding that is under preparation within the IPN 
METODIKA project by the Technopolis Group is scheduled to be gradually implemented (for 
more details also see Section 2.3). 
In 2014, the single largest recipient of institutional funds was the ASCR with €171m 
(CZK4.5b), which constituted 34% of the total institutional funding. Nevertheless, the ASCR 
increasingly acquires funding from other sources than its own public budget line. According 
to ASCR (2014), the total budget amounted to €486m (CZ12.6b) in 2013, of which thus 
public institutional funding only accounted for 35%, which represents a significant drop 
from 60% in 2009; the gap was filled mainly by the increase of resources received from 
budget lines of other public R&D providers and by the growth of funding from the EU, the 
combined share of which doubled from 17% in 2009 to 34% in 2013, while the rest was 
covered by increased funding from other external sources outside of the public budget. It is 
important to note that the institutional funds that are allocated to the ASCR in its own 
public R&D budget line become re-distributed between the member research institutes 
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using results of its own internal evaluation methodology that involves international peer 
review.  
Overall, however, the largest share of the national institutional funding, about 44% and 
€217m (CZK5.6b) in 2014, is channelled to the sector of higher education by the MEYS, 
which distributes the funds among the individual higher education research organisations 
using results of the formulae-based evaluation. Much smaller amounts are channelled 
through other ministries which predominantly use the institutional funds to support field-
specific research centres under their own umbrella (the Ministry of Agriculture, the Ministry 
of Health, the Ministry of Culture, and others). National public co-financing of the EU 
Structural Funds dealing with R&D and innovation that is administered by the MEYS and 
MIT and that amounted to €53m (CZK1.4b) in 2014 is also classified under the category of 
institutional funding in the public R&D budget. 
The main providers of competitive project funding are the GA CR which allocates grants for 
basic research and the TA CR which supports applied research, experimental development 
and innovation. GA CR had an annual budget of €133m (CZK 3.5b) in 2014, which more 
than doubled from €59m (CZK 1.5b) in 2008. The legal statute of TA CR was adopted by 
the government in December 2009 and the first programme ALFA was launched in March 
2010. The first projects were selected in November 2010 and started at the beginning of 
2011. Another three programmes funded by TA CR called BETA, OMEGA and Competence 
Centres were launched in 2012, two additional programmes GAMA and DELTA started in 
2014 and EPSILON replacing ALFA starts in 2015. As a result, the budget of TA CR has 
grown significantly in recent years from €34m (CZK 0.9b) in 2011, to €114m (CZK 3.0b) in 
2014. 
GA CR uses international peer review to guide the allocation of funds. The main funding 
instrument is a standard grant project, the call for which is announced annually and can 
have duration of 1-3 years. The applications are assessed by an expert panel (39 panels in 
5 disciplinary areas) on the base of two-step review procedure; first, the applications are 
evaluated by two internal reviewers and then only those that satisfy minimal quality 
requirements (about two-thirds of the applications) are evaluated by at least two foreign 
reviewers (Slovaks are not perceived as foreigners). Other funding instruments of GA CR, 
i.e. postdoctoral grants, junior grants, projects for excellence in basic research and 
international bilateral grants, are evaluated using similar procedures. TA CR evaluates 
project proposals using peer-review but only with the help of domestic experts. 
The major part of project funding for applied research used to be administered by the MIT, 
primarily through the TIP research programme the budget of which, however, has been 
significantly reduced with expenditures of €121m (CZK 3.0b) in 2012, €78m (CZK 2.0b) in 
2013 and €41m (CZK 1.1b) in 2014, and is earmarked to continue shrinking in the 
medium-term budget outlook. From 2017 onwards the MIT is supposed to cease to 
administer competitive funding from the national public R&D budget and completely pass 
this role to the TA CR. The MEYS also has a significant budget devoted to project-based 
funding, which is directed primarily towards the higher education sector, including the 
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competitively allocated funding for research conducted by master and doctoral students – 
the so-called “specifický výzkum” – with a budget of €45m (CZK 1.2b) in 2014; there are 
no plans to transfer this funding under the GA CR or TA CR. 
Much smaller amounts of project funding are channelled through five other ministries 
which provide funding through their individual research programmes (the Ministry of 
Agriculture, the Ministry of Culture, Ministry of Defence, Ministry of Health and Ministry of 
Interior). However, past experience has shown, that these programmes, while nominally 
project funds, are often used as a source of institutional funding for research institutes 
controlled by the given ministries and also as means of research funding for the needs of 
these ministries. 
According to the International Audit of Czech RDI (Arnold, 2011, pg. 56), the share of 
project funding allocated competitively was too high, exceeding proportions that many 
countries deem as dangerous, and one of the key recommendation was that in order to 
assure stability and opportunities for long-term planning institutional funding should 
comprise at least 50% of the public R&D budget. Despite initial reform plans to reach 60% 
to 40% ratio between project (or targeted) and institutional funding by 2015, the policy 
has been updated in this respect and the ratio has stabilized around 50% over 2012-2014 
and is projected to remain roughly at the same level in the medium-term budget outlook 
until 2017. 
Generally speaking, the key challenge that needs to be addressed for achieving more 
efficient and effective functioning of the funding allocation system is underdeveloped 
evaluation culture.  As also pointed out by the International Audit of Czech RDI (Arnold, 
2011, pg. 56), the system of R&D evaluation is grossly outdated, focused on counting 
outputs rather than aiming at assessing policy interventions, outcomes and their impacts, 
and hence provides limited feedback to the policy and programme development; there is a 
need for a fundamental upgrade of evaluation practices.  
 
2.5.3 R&I funding 
Until recently the government stimulated RDI in the business sector predominantly through 
direct subsidies. The programme TIP administered by the MIT provides subsidies to applied 
industrial research and R&D collaboration between the business and academic sectors. The 
OP EI is designed to address the needs of industry, from start-ups to mature firms, 
including Potential programme promoting R&D capacities in enterprises, the Cooperation 
programme for technology platforms and clusters, Prosperity supporting technology parks 
and business incubators and the Start, Development, Innovation, Progress and Guarantee 
programmes that help start-ups and SMEs to overcome the limited availability of external 
funding. Most importantly, TA CR, which was established in 2009 as prospectively the main 
provider of direct subsidies to applied research and innovation, launched a portfolio of new 
programmes, including ALFA and Competence Centres. Subsidies channelled through the 
MIT and TA CR, which amounted to about €150-200m (CZK 4-5b) annually over the period 
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2010-2014, are the dominant direct tools for stimulating innovation. Several regions have 
implemented innovation voucher programmes; however, their funding has been limited to a 
combined value of less than €1m (CZK 26m) annually, hence very small so far. 
Yet there has been a shift from a system traditionally based on direct subsidies towards a 
wider portfolio of support measures. An R&D tax credit scheme has been launched in 2005 
to stimulate private R&D expenditure. The new tax regulation enabled enterprises to deduct 
expenditures on R&D carried out for their own needs from the tax base, a major change as 
there was no measure of this kind before. In 2005, 27% of R&D performing businesses 
used the tax relief and the indirect support of R&D amounted to €27m (CZK 0.82b). In 
2012, the number of companies drawing on indirect support to R&D was already around 
45% of companies performing R&D activities and the indirect support of R&D reached 
almost €77m (CZK 1.99b). About 80% of firms that use the indirect R&D support have less 
than 250 employees and 70% of them are domestic-owned; hence this instrument proves 
to be particularly suitable for promoting R&D in domestic SMEs (CZSO, 2014b). Since 2014 
the tax credits have been extended to the purchase of R&D services from research 
organisations. So far there has not been any evaluation of this support scheme.  
Venture capital market is underdeveloped. Venture capital investment was limited to €12m 
in 2010, €8m in 2011 and dropped to less than €1m in 2012 and 2013. Only several 
companies receive venture capital funding each year (Eurostat, 2014). Public measures to 
support venture capital are missing. Since 2011 the MIT has attempted to establish a 
public-private seed fund to kick-start the market. A budget of €53m funded from the OP EI 
was earmarked for the fund, of which €32m to the SEED instrument for early-stage and 
€21m to the VENTURE instrument for expansion funding. However, in 2013 the launch of 
the seed fund became complicated by the ruling of the Office for the Protection of 
Competition due to dispute over the tender for the fund’s custodian and in 2014 the 
project was eventually terminated by the government (CzechTrade, 2014). 
 
2.6 Smart Specialisation (RIS3) 
Regional authorities, consisting of 14 self-governing regions at the NUTS3 level, do not 
have any legally binding responsibilities in RDI policy. Yet the law does not prevent them 
from launching own RDI initiatives, which is, however, difficult given their restricted 
budgets. So far their main role has been in catalysing the EU Structural Funds projects, 
primarily those funded from the OP RDI. The South Moravian region is the main exception 
that proves the rule, representing the national role-model of regional innovation policy with 
dedicated authorities, a well-functioning innovation agency and a dialogue with the 
business community; for more information see (RISJMK, 2013). Several other regions are 
attempting to emulate this model with various degrees of success, most prominently 
Moravia-Silesia, Liberec, Zlín and Hradec Králové regions, while most of the other regions 
have either only paid a lip service or ignored the need to developing regional innovation 
policy altogether. 
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MEYS accepted the responsibility for designing the RIS3 strategy and appointed the so-
called RIS3 Coordination Board in November 2012 (MEYS, 2014). Regional RIS managers 
were selected in April 2013 and the national RIS3 facilitator was assigned in September 
2013; arguably facing a very tight schedule. The regional managers were appointed and 
funded by the MEYS. Only South Moravia and the Capital City of Prague have started to 
work on their RIS3 strategies in a bottom-up manner, independently of the national 
initiative. It remains to be seen to which extent the top-down approach to crafting of the 
regional RIS3 strategies will make a tangible difference on the ground, especially in the 
regions where indigenous initiative has been very limited so far. The National RIS3 Strategy 
has been approved by the government and submitted to the European Commission in 
December 2014. Management and implementation of the RIS3 strategy has been 
transferred under the auspice of the Deputy Prime Minister for the Science, Research and 
Innovation in Office of the Government of the Czech Republic.  
The National RIS Strategy is organized around five pillars: i) Entrepreneurship and 
innovation; ii) R&D; iii) Human resources; iv) Digital agenda; and v) Social innovation. The 
key enabling technologies have been specified as: i) Advanced materials; ii) 
Nanotechnology; iii) Micro- and nano-electronics; iv) Advanced production technologies; v) 
Photonics;  vi) Industrial biotechnology; vii) Knowledge for digital economy, cultural and 
creative industries; viii) Social science knowledge base for non-technical innovation. At this 
point, there are four national S3 platforms: i) Engineering; ii) Information and 
telecommunication services and software; iii) Transport equipment; and iv) 
Pharmaceuticals and life technologies; more are expected to be added as the 
entrepreneurial discovery process gets unfolded. The strategy provides detailed 
consideration of financial requirements from the ESIF; however, there are no details on the 
use of national funds beyond the ESIF co-financing; this is going to be specified by the 
government annually. Monitoring reports are expected to be published annually and 
evaluation is scheduled to be conducted every two years in order to feed into the update of 
the strategy.  
So far RDI policy making has been fairly centralized. Co-ordination between the national 
and regional level innovation strategies has been very weak, if not missing altogether. 
National innovation strategy has addressed the regional aspects of innovation vaguely 
only. Drafting of the national RIS3 strategy involves, at least formally, a coordinated action 
of the national and regional authorities on the topic of innovation policy; hence 
representing a much needed opportunity for establishing a nation-wide debate on this 
topic. Needless to say, it is pertinent that this dialogue is sustained beyond this particular 
purpose and elements of multilevel governance of the RDI system are implemented in the 
future. 
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2.7 Evaluations, consultations, foresight exercises 
Methodology of Evaluation of Research Organizations and Evaluation of Finished 
Programmes (valid for years 2013 - 2015), so-called Metodika 2013 (CRDI, 2013b), gives 
the official guidelines for evaluation of public R&D support. A major asset of the evaluation 
system is the regular, detailed and complete collection of data in the Research and 
Development and Innovation Information System of the Czech Republic, which provides 
open access to information about publicly funded support measures, projects and their 
outputs (for more details see Section 3.3.2). However, the data is underutilized for 
evaluation purposes. The evaluation methodology is limited to monitoring and descriptive 
tabulations of the data but does not provide strategic intelligence in terms of assessing the 
policy interventions, counterfactual analysis, impact evaluation and international 
benchmarking that can be taken on board in policy and programme development (for more 
details see Sections 2.3, 2.4 and 2.5.2).  
The Update of the National Research, Development and Innovation Policy 2009-2015 with 
an outlook to 2020 has been approved by the government resolution No. 294 on 24th April 
2013 (CRDI, 2013a). The update provides a comprehensive evaluation of the progress 
achieved so far in implementing the RDI reform. The main aim of the update is to improve 
conditions for innovation, knowledge transfer and diffusion of frontier technologies. The 
update revolves around four priority areas: i) Supply of high-quality human resources; ii) 
Enhancing the framework for transfer and utilization of knowledge; iii) Boosting the 
innovative capacity in the business sectors and iv) Improving strategic management of the 
system. As the keystone has been flagged the field of human resources, because this is 
deemed to be essential for successful operation of the newly constructed research centres 
and infrastructures. Another purpose of the update is to re-align the reform agenda with 
the government medium-term budgetary plans in public R&D spending, which have been 
significantly downsized by the economic crisis and prolonged recession. Nevertheless, the 
government maintains its commitment to meet the 2020 national target of 1% of 
government spending on R&D as % of GDP. So far a macroeconomic model has not been 
used to assess the RDI impact on economic growth and there are no plans to create one. 
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3. National progress towards realisation of ERA 
3.1 ERA priority 2: Optimal transnational co-operation and 
competition 
In the context of the National Policy of RDI 2009-2015 implementation, new long-term 
national priorities of oriented RDI (for the period until 2030) that are largely in line with the 
grand challenges of Horizon 2020 were prepared by panels of experts at the end of 2011 
and approved by the government in mid- 2012 (CRDI, 2012). More specifically, the priority 
research fields were identified within six broader areas: i) Competitive knowledge-based 
economy; ii) Sustainable energy and material resources; iii) Environment for quality life; iv) 
Social and cultural challenges; v) Healthy population; and vi) Safe society. The 
governmental ministries, ASCR, GA CR and TA CR have responsibility for implementing the 
priorities within their authority; they are taken into account for the preparation of proposal 
of state budget expenditures for 2014 and later.  
The Czech Republic has become a member of five Joint Programming Initiatives (JPIs), all 
four from the first wave of 2009 and only one from the second wave of 2010: 1) 
Neurodegenerative Disease Research, 2) Agriculture, Food Security and Climate Change, 3) 
Cultural Heritage and Global Change, 4) Healthy Diet for a Healthy Life and 5) The 
Microbial Challenge – An Emerging Threat to Human Health. However, the Czech Republic 
plays a rather passive role in the JPIs. The Czech Republic is also formally engaged in all 
five Joint Technology Initiatives (JTIs). But only in two of them, namely ARTEMIS and 
ENIAC, have been issued calls for proposals by the MEYS.  
According to Acheson et al. (2012), the main constraints regarding to Czech participation in 
the JPIs are budgetary restrictions, limited human resources, lack of coordination at the 
national level and insufficient compatibility of the national and European rules and 
procedures. It is therefore no wonder that albeit there are several programmes at the 
national level which support research on topics relevant to the strategic research areas of 
the JPIs, the national funding providers have not come forward with direct involvement in 
terms of financial participation so far. Šebková, et al. (2011) conclude that national 
financial support to joint programs is very low; ERA-NETs funding is close to zero and 
bilateral agreements account for a very low part of research funding.  
As far as national participation in European Innovation Partnerships (EIPs) is concerned, 
this is very early to evaluate.  Four users from the Czech Republic registered and they are 
involved in 33 out of 293 initiatives in the pilot EIP on Active and Healthy Ageing since 
2011; hence, there is a small number of highly active participants.  The other four existing 
EIPs are too new to assess, indeed. Given evidence on the participation in other joint 
research efforts discussed above, however, it is reasonable to expect that the involvement 
of Czech entities is not likely to be particularly high, unless national policies stimulating 
indigenous initiative are put in place. 
The Czech Republic is a member of the most of the intergovernmental organisations in ERA 
as well as the member of projects of large European infrastructures (ESFRI). The Roadmap 
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for Large Research, Development and Innovation Infrastructures in the Czech Republic was 
approved by the Government in March 2010 (updated in May 2011). Several large research 
infrastructural projects, including pan-European infrastructures, are under construction and 
gradually opening, which have a potential to open new avenues for internationally co-
operation. The ELI project aims at creation of a large laser infrastructure; this is the only 
ESFRI Roadmap project which has a base in the Czech Republic.  
The Czech Republic participates in the European Space Agency, European South 
Observation, European Molecular Biology Conference, CERN, OECD, EUROATOM, EFDA and 
other international programmes. ASCR and GA CR are the members of the European 
Science Foundation. Since 1993 research teams from the Czech Republic participate in the 
EU’s framework programmes. Because of the existing and well-functioning environment for 
research co-operation within the EU, bilateral research agreements are oriented toward 
third countries; they are organized either on intergovernmental level or on inter-
institutional level, involving, for instance, the GA CR and ASCR. However, judging from the 
funding flows, the activity under these agreements is limited and most of them are 
focused on establishing contacts, networking and promoting mobility, hence not joint 
research projects. In addition, there is a weak link between the Czech joint programmes on 
one hand and the European programs on the other hand.  
MEYS which is the main intermediary body responsible for international cooperation in 
research manages a host of programs that support international cooperation in research, 
namely EUREKA, COST, EUPRO, INGO, KONTAKT (devoted to financing bilateral projects 
based on intergovernmental agreements primarily with third countries) and GESHER/MOST 
(with Israel). As a member of the European Science Foundation, GA CR coordinates and co-
funds its programs in the European Collaborative Research (EUROCORES) framework (these 
programs comprise less than 1% of GA CR budget), Research Networking Programmes, 
Research Conferences, Forward Looks and Member Organisations Fora (however, there has 
been limited activity in the latter four initiatives so far). GA CR further provides funding for 
international bilateral research grants (the combined funding for the bilateral grants 
comprises about 2% of GA CR budget only). TA CR has launched a new DELTA programme 
with the aim to facilitate international cooperation of support to applied research and 
experimental development through joint programmes with technological (and innovation) 
agencies in non-European countries. The Visegrad fund and the Financial Mechanisms of 
the EEA/Norway also promote research cooperation with the respective countries. 
National Information Centre for European Research (NICER) that operates under the 
Technology Centre of the ASCR provides comprehensive support for the participation of 
national teams in international research cooperation, especially in the EU Framework 
Programmes. Czech Liaison Office for Research, Development and Innovation (CZELO) in 
Brussels supports the successful integration of the Czech research into the European 
research cooperation, particularly through the EU Framework Programmes for Research 
and Development. The office provides free services to researchers from all fields and all 
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research bodies in the Czech Republic. CZELO is a project managed by the Technology 
Centre of the ASCR and financially supported by the MEYS 
Bilateral agreements under GA CR recognize the assessment of proposals conducted by the 
partner funding agency, i.e. the National Science Foundation of Korea, National Science 
Council of Taiwan and Deutsche Forschungsgemeinschaft; however, it is not obligatory that 
the evaluation conforms to international peer-review standards (although this is typically 
the case). DELTA programme of TA CR that starts operation in 2014 recognizes evaluations 
of the partner technology (or innovation) agency as the basis for national funding 
decisions. Again, it is not explicitly required in the background documentation that the 
evaluation process of the partner agency conforms to international peer-review standards.  
 
 
3.2 ERA priority 3: An open labour market for researchers. 
Facilitating mobility, supporting training and ensuring attractive 
careers 
3.2.1 Introduction 
In 2013, there were about 43 thousands researchers (full-time equivalent), of which nearly 
half were based in the business sector, a third in the higher education sector and slightly 
less than a fifth in the government sector. In terms of intensity, there were 3,300 
researchers per million people, which means close to the EU28 average but roughly half of 
the level maintained in top performing countries. The number of researchers roughly 
doubled during the ten-year period between 2004 and 2013, whereas it remained roughly 
stable during the main crisis period of 2008-2010 and even increased by about 17% over 
the recent period of 2010-2013; hence the labour market for researchers is steadily 
expanding.  
The approach to RDI human resource management is unsystematic. Human resources 
management practices in the public sector need to be revised in order to reduce the 
widespread in-breeding, make career progression paths more transparent and intensify 
competition for posts. Czech institutions or organisations have not received, not even a 
single one, the Commission acknowledgement for progress in the context of the HR 
Strategy so far, i.e. there is no organisation with the "HR Excellence in Research" badge. 
Two institutions, namely the ASCR and Central European Institute of Technology (CEITEC), 
have endorsed the Charter & Code. But there is no HRS4R acknowledged institution.  
Arnold (2011) points to the fact that human resources management practices in the public 
sector need to be revised in order to reduce the widespread in-breeding, make career 
progression paths more transparent and intensify competition for posts. There is a 
considerable scope for making better use of research internationalization in the public 
sector, the limited extend of which is in a sharp contrast to the pivotal role of foreign 
affiliates in the business sector. Only less than 10% of researchers are foreign and half of 
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those are Slovaks, which is very small proportion by international standards. An explicit 
internationalization strategy of the public research system is lacking. 
 
3.2.2 Open, transparent and merit-based recruitment of researchers 
Generic labour laws set employment conditions. General conditions of employment and the 
role of the state administration (especially the Ministry of Labour and Social Affairs) are 
regulated by the Labour Code (Act no. 262/2006 Coll.) and the Act on Employment (Act. no. 
435/2004 Coll.), if not stipulated by a special regulation. Most public research institutions 
conduct their activities in accord with the Act on Public Research Institutions (Act no. 
341/2005 Coll.). For higher education institutions the main human resources issues are 
defined by the Tertiary Education Act (Act No. 111/1998 Coll.), which has been amended 
seventeen times and a novelization of which is in the pipeline, sets rules for the operation 
of higher education institutions, including the appointment of professors and docents.  
Nevertheless, the system is based on a high level of institutional autonomy. Research 
institutions have extensive self-governing rights and decision-making powers which have 
been further decentralized to the faculty and departmental level. Generally speaking, 
research institutions employ individual academics in a market driven decentralized system; 
the recruitment process is an internal affair of every institute. Hence, it is hard to assess 
policy-measures that define the way researcher’s recruitment is carried out. 
Likewise, career development is a matter for internal institutional regulations in higher 
educational institutions. The Higher Education Act gives the task of appointing professors 
and obtaining venium docendi (habilitation) to the Scientific Board of the higher education 
institution. Professors are appointed by the President of the Czech Republic on the 
recommendation of the higher education institution’s council, submitted through the MEYS. 
Academic careers are hierarchical and consecutive and the academic titles have lifelong 
and countrywide validity, even though the underlying conditions vary by institution. The 
academic labour market is quite internally oriented. There is a very low horizontal mobility 
of academic staff leading to a clear pattern of inbreeding and limited competition for 
posts. Opportunities for early career researchers are weak, post-doc funding remains 
limited and often not allocated on competitive basis. 
The legislation rules provide an open access for foreign researchers to be employed at 
academic positions, especially in case of EU citizens. There are also several measures 
simplifying inward mobility of researchers from the non-EU countries, such as the Scientific 
Visa Package. Attracting talented doctoral students from abroad is high on the agenda on 
some research institutes, albeit the achievement of this goal is rather difficult because of 
low financial support available (through there is the Fellowship J. E. Purkyně awarded at 
the ASCR). A programme called NÁVRAT, i.e. “return" in English, administered by the MEYS is 
aimed to improve conditions for re-integration of top researchers coming back from 
abroad.  
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3.2.3 Access to and portability of grants 
Overall, public research funders, such as GA CR and TA CR, support almost exclusively 
resident researchers, with the exception of special programmes and funding based on 
agreement for international research cooperation, which is however fairly limited. Funding 
for non-residents is generally not possible, unless they become residents for the purpose 
of conducting the research project. Language barriers for participation of foreign 
researchers are important; the main exception represents the grant programmes of GA CR 
that require applications exclusively in English, however, the background documentation 
remains to be accessible in Czech only.  
National research funding programmes do not allow transferability of a grant to another 
country, thus research projects funded by national research programmes must be 
performed in the Czech Republic. An entity from other EU country may participate in a 
public R&D tender provided that such participant does not apply for support from the 
public funds of the Czech Republic. Hence, reciprocity is required in any international 
partnership. None of the existing laws or documents explicitly elaborates on access to 
research infrastructures by non-resident researchers and there are no specific measures to 
facilitate cross-border access to research infrastructures.  
 
3.2.4 EURAXESS 
The EURAXESS Centre is funded by the MEYS through the EUPRO programme: Project 
„EURAXESS Czech Republic 2012 - 2015“. The national network created by the project 
includes two service centres in Prague and Brno and regional contact points in eight cities. 
Services Centres provide personalized assistance on the challenges faced by researchers 
and their families when relocating, including visas, work permits, accommodation, legal 
issues, social security, medical care, pension rights and taxes, family support, language 
courses, day care, schooling, research funding, etc. 
There is no legislation dealing with the online publication of publicly-funded research jobs. 
It is therefore not formally required to advertise new positions nationally and 
internationally in media, thus in practical terms only a minority of vacancies is announced 
through EURAXESS and other international portals. In 2011, the MEYS admitted that the 
awareness of EURAXESS Jobs portal was very low (VERA 2011), however, the situation has 
improved markedly in recent years: the number of accesses to the EURAXESS Jobs portal 
increased from 13,053 in 2011 to 30,263 in 2014, the number of queries to the 
EURAXESS network nearly quadrupled from 3,310 in 2011 to 12,427 in 2014 and the 
number of personal assistances provided by the EURAXESS service centre in Prague tripled 
from 580 in 2011 to 1742 in 2014, including assistance to 400 foreign researchers. 
According to the European Commission (2014d), the number of researcher posts 
advertised through the EURAXESS Jobs portal per thousand researchers in the public sector 
was 22.8 in the Czech Republic compared to 39.9 among the Innovation Union reference 
group and an EU average of 43.7 in 2013, hence still remaining below its full potential. 
Since 2007, in line with the Council Directive 2005/71/EC on a specific procedure for 
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admitting third-country nationals for the purposes of scientific research, researchers from 
non-EU countries and their families can apply for a Scientific Visa for the purpose of 
carrying out a research project at a public as well as private Czech research organization 
(based on the Hosting Agreement). Hence, there is special regime with lower administrative 
burden and shorter processing period for a long-term residence permit of researchers of 
foreign origin. Nevertheless, there is a considerable scope for making better use of 
research internationalization in the public sector. 
 
3.2.5 Doctoral training 
Universities are fairly autonomous in the way they develop doctoral training, which makes 
it extremely difficult to derive general conclusion on the degree to which the Principles for 
Innovative Doctoral Training are taken into account. Generally speaking, there are very 
large differences in this respect. Standardisation of PhD programmes is being currently 
tackled within the reform of tertiary education based on the debate corresponding to 
challenges identified in the White Paper on Tertiary Education (adopted by the Government 
in 2009;1). However, the policy does not refer nor takes into account the Principles for 
Innovative Doctoral Training so far, i.e. there is no support that specifically promotes the 
setting up and running of innovative doctoral training programmes. 
 
3.2.6 HR strategy for researchers incorporating the Charter and 
Code 
None of the Czech institutions or organisations has received the Commission 
acknowledgement for progress in the context of the HR Strategy so far, i.e. there is no 
HRS4R acknowledged organisation with the so-called "HR Excellence in Research" badge. 
Nevertheless, three institutions, namely the ASCR, Charles University in Prague and CEITEC 
- Central European Institute of Technology, have endorsed the Charter & Code, so the 
underlying principles have been transposed at national level by individual institutions, most 
notably in the sector of public research institutes. In contrast, with the major exception of 
Charles University, there is generally little awareness and support of the principles in the 
higher education sector. So far national authorities have not encouraged public funded 
institutions to adhere to the Charter & Code. 
 
3.2.7 Education and training systems 
Labour market for researchers continues to suffer from a lack of experts. According to the 
data from the Czech Statistical Office (2014a), the number of PhD graduates has 
stagnated in recent years and there is a long-term tendency for the proportion of science 
and technology tertiary students to decrease in comparison to those of social science and 
                                              
1
 http://www.msmt.cz/reforma-terciarniho-vzdelavani/bila-kniha  
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humanities, however, policies to boost the supply of (post)graduates in science and 
technology are lacking. The assessment of MIT (2011b) concluded that because the reform 
of tertiary education remains uncompleted, there has been an unchecked expansion of 
university graduates, the quality of which is however hard to judge. As shown by National 
Training Fund (2012), opportunities for early career researchers are weak, post-doc funding 
remains limited and especially in the university sector often not allocated on competitive 
basis, which leads to in-breeding. Arnold (2011) reported that management of research 
groups is underdeveloped, the groups tend to be very small, locked into existing research 
trajectories and lacking interdisciplinarity, there is little use of career development plans 
and mobility among researchers is poor. Overall, the approach to research human resource 
management is unsystematic. 
Apart from several smaller initiatives, the most prominent measure to increase the 
attractiveness of research careers is the Česká hlava (Czech Head) project which awards 
an annual prize to distinguished Czech scientists. Recently this award has been extended 
for talented secondary students. Several projects supported by the EU Structural Funds 
entitled Otevřená věda (Open Science) and Otevřená věda regionům (Open Science for 
Regions) were organized by the ASCR in 2005 and 2007, respectively, the former was 
prolonged as Otevřena věda II, III and IV over the period 2009-2015; the projects were 
targeted at secondary school teachers and assisted them in directing students to research 
careers. In addition, activities aimed at increasing the attractiveness of research careers 
and popularising research include science and technology popularisation courses under the 
OP EC and development of science learning centres under the OP RDI.  
NÁVRAT (RETURN) brain gain programme with the aim to improve conditions for re-
integration of top researchers coming back from abroad is operated by the MEYS since 
2011. The ASCR awards the Fellowship J. E. Purkyně to attract outstanding scientists from 
abroad since 2004; both Czech scientists working abroad and top foreign scientists are 
eligible. The MOBILITY programme is focused on outwards mobility of researchers 
supporting short-term internships at foreign partner institutions. Bilateral mobility of 
students and researchers is funded by the MEYS from the EU Structural Funds. MEYS also 
runs the Scholarship Awards within the Foreign Development Assistance Programme 
intended for talented Master and PhD students coming from third countries and studying in 
public universities. Scientific Visa Package that simplifies procedures required by 
researchers from non-EU countries to apply for a long-term residence permit was 
established in 2007; this regime only applies to foreign nationals employed at universities 
and public research organisations.  
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3.3 ERA priority 5: Optimal circulation and access to scientific 
knowledge  
3.3.1 e-Infrastructures and researchers electronic identity 
The keystone of the Czech e-infrastructure for research is CESNET (Czech Education and 
Scientific NETwork); national partner of GÉANT and EGI.eu and the coordinator of NGI 
(National Grid Infrastructure). CESNET, association of legal entities, was established in 
1996 as a joint venture of universities and the ASCR. Its main goals are: i) Operation and 
development of the Czech NREN; ii) Research and development of advanced network 
technologies and applications; and iii) Broadening of the public knowledge about the 
advanced networking topics. CESNET participates in a number of international projects 
(DANTE shareholder, TERENA member, Internet2 partner, European GN2 project and GLIF 
participant).  
CESNET is an integral part of the Roadmap for Large Research, Experimental Development 
and Innovation Infrastructures in the Czech Republic (integrated in the ESFRI Roadmap), 
approved by the government in March 2010 (updated in May 2011). The CESNET is 
developing this infrastructure with support from public budgets under two major RIs 
projects, namely CESNET Large Infrastructure and Extension of the National R&D 
Information Infrastructure in Regions (eIGeR). The reconstruction of the CESNET2 backbone 
network started in 2011; it forms the necessary foundation for the other components of 
the national information e-infrastructure. 
IT4Innovations is a unique project (integrated in the ESFRI Roadmap) of a national Centre 
of Excellence in the field of information technologies. The centre enables the concentration 
of a wide range of scientific disciplines relating to information technologies and thus 
achieves development in respective spheres. Part of the project is acquisition of a high-
performance supercomputer which has been put into operation in 2014 and which ranks 
among the top 100 most powerful supercomputers in the world. IT4Innovations is the 
national partner of PRACE (Partnership for Advanced Computing in Europe). 
EDUROAM infrastructure has been implemented by CESNET. The purpose of the 
eduroam.cz project is to support and spread IP mobility and roaming within the Czech 
NREN. CESNET task is to in coordinate and propagate eduroam ideas at national level, 
supporting academic organisations interested in cooperation with eduroam.cz project. 
Moreover, CESNET operates the Czech academic identity federation eduID.cz project. The 
eduID.cz federation is based on the Shibboleth project developed by Internet2 and is a 
member of eduGAIN and participates in REFEDS. CERIT Scientific Cloud offers storage and 
computing resources and related services, including support for their experimental use. 
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3.3.2 Open Access to publications and data 
Generally, there is growing consensus in the scientific community to allow open access to 
publications whenever possible, but the concern is about the funding for such 
arrangements. Hence, open access to both scientific publications and data for research 
purposes hinges on poorly developed infrastructure and institutional framework. The 
awareness of open access movement ideas is concentrated among library staff, but there 
are efforts to raise the awareness, such as the portals www.openaccess.cz and 
www.dspace.cz, which promote the open access ideas among researchers. Policies with 
regards to access to scientific publications are fragmented; the deals are negotiated 
separately by the individual research organizations. National open access repository does 
not exist. 
Archambault, E., et al. (2014) reported that during the period 2008-2013 the percentage of 
peer-reviewed articles published in open access journals was 6.8% compared to the EU28 
average of 9.4% in the green category, i.e. self-archiving of final peer-reviewed 
manuscripts in institutional or subject repositories and 9.6% compared to the EU28 
average of 8.6% in the gold category, i.e. pay to publish in open access, respectively. 
Hence, there is a noticeable room for improvement in using the green open access, but 
there is already a sizeable potential for leveraging the possibility of gold open access, 
which however makes a difference only if the author actually pays for it. Unfortunately, no 
data is available on the latter.  
According to OpenAIRE, there is no official government mandate to deposit research output 
arising from grants, no research funding agency requires that, nor exists any university 
which mandates to deposit published journal articles in its open repository. OpenAIRE gives 
a list of 11 open access repositories and 4 research data repositories scattered in libraries 
of various research organisations and universities. Although the Berlin Declaration has 
been signed by eight organisations, including the GA CR, ASCR and Masaryk University, and 
there is a growing number of open access journals published by the Czech research 
organisations, the adoption of open access to scientific publications remains in the early 
phase. 
The Update of the National Research, Development and Innovation Policy 2009-2015 with 
an outlook to 2020 admits that policies with regards to access to scientific publications, i.e. 
journal subscriptions, are fragmented; the deals are negotiated separately by the ASCR and 
universities, which leads to inefficiencies, and that there is a need for forming consortium 
at the national level for this purpose (CRDI, 2013a). It is concluded that “access to 
information infrastructure for the system of research, development and innovation is not 
provided in a satisfactory manner”. Admittedly, there is a looming deficit in this respect 
that represents a major challenge for policy. The CRDI at its 291st meeting in February 
2014 approved a resolution on open access to publicly funded scientific publications that 
recommends to develop a national strategy of open access, intensify support to efforts of 
research organizations to facilitate open access and encourages research funding agencies 
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to require open access.  Nevertheless, there are currently no measures or funding at the 
national level for promoting open access publishing. 
The Czech Statistical Office (CZSO) provides confidential statistical data for scientific 
research purposes. Microdata can be provided only on the basis of a special contract, which 
stipulates conditions for the data confidentiality protection and the exact way of data use 
in accordance with the legislation. Data is provided in the form not allowing the direct 
identification of reporting units only to domestic and foreign legal entities the primary 
mission of which is scientific research. However, microdata is provided only from a handful 
of surveys, especially access to firm-level data is severely limited. In addition, there is no 
safe-room in the CZSO and on-line remote access to micro data for scientific purposes is 
not provided; each data release needs to be negotiated separately, which hinges merging 
of datasets, creating longitudinal panel data and hence undermines efforts to conduct 
research on the data systematically over long-term. 
The CRDI administers the Research and Development and Innovation Information System 
of the Czech Republic (ISVaV), a well-developed information system for a collection, 
processing, publication and utilisation of data about publicly funded research activities, 
projects and their outputs. Access to this information system is required to be open and 
available on-line by the law. The system consists of the following databases: 1) Central 
register of R&D projects (CEP); 2) Central register of Institutional Research Plans (CEZ); 3) 
Information register on R&D results (RIV); 4) Central register of R&D Activities (CEA); and 5) 
Register of public R&D tenders (RES). Most of the datasets are updated quarterly and direct 
searching in the databases is possible through the user application. 
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4. Innovation Union 
4.1 Framework conditions 
In 2008, a comprehensible reform of the research, development and innovation system 
was launched. The reform is outlined in the National RDI Policy of the Czech Republic 
2009–2015 (CRDI, 2009) and the Update of the National Research, Development and 
Innovation Policy 2009-2015 with an outlook to 2020 (CRDI, 2013a). The main act 
regulating the field of research, development and innovation is the Act No. 130/2002 Coll. 
on the Support of Research and Development from Public Funds and on the Amendment to 
Some Related Acts, which has been substantially updated by the reform amendment 
announced as Act. No 211/2009 Coll. The reform profoundly changed the governance of 
system and the responsibilities of the main players, namely mandated the CRDI to become 
the central player with the main strategic and coordinating role in policy making, 
established the TA CR as the dominant supporter of applied research and increased the 
share of public funding allocated on a competitive basis. The reform also brought to the 
attention of policy-makers the role of innovation and private-public research linkages for 
national competitiveness. 
Business investment in research and innovation is not only supported by direct subsidies 
anymore, which used to be the dominant policy measure, but by much broader portfolio of 
instruments, including R&D tax credits both for internal activities as well as purchase of 
external inputs from research organizations, support programmers for joints research 
projects between the public and private sectors, regional innovation voucher programmes 
and measures planned to boost the venture capital market. Nevertheless, RDI policies 
continue to be focused predominantly on the supply side; neglecting the potential of using 
demand side instruments, and deeply rooted in the linear model of innovation. 
Coordination between the various policy instruments, including within the supply side, is 
underdeveloped and their synergies remain unexploited. Public procurement is not seen as 
an instrument to promote innovation.  
 
4.2 Science-based entrepreneurship 
The ublic research system is relatively strong consisting of an elaborate network of public 
universities and research institutes. However, a major weakness of the public research 
sector has traditionally been limited knowledge transfer from science to practical 
applications, poor commercialization of scientific outputs and underdeveloped 
entrepreneurship culture among scientists. Professors rarely get involved in spin-offs. No 
official data is available on the number of start-ups involving scientists, which is at least 
partly attributable to the fact that anecdotal evidence suggests that they are extremely 
rare. The evaluation system, including the allocation of institutional funding at the 
organization level and career progression paths at the individual level, heavily relies on 
indicators of scientific output and does not motivate scientists to get involved in 
commercialization activities. Public support specifically to science-based entrepreneurship 
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is lacking, except only for funding for the establishment of technology transfer offices (for 
more details see Section 4.4).  
Nevertheless, there have been bottom-up efforts to promote university spin-offs at the 
level of individual institutions that deserve to be mentioned. Several business incubators 
for start-up companies of university students have been opened in the higher education 
sector, for example, InovaJET at the Czech Technical University in Prague has already 
supported about 80 projects since 2010 and xPort at the University of Economics in Prague 
and Point One at the Czech University of Life Sciences Prague have been just launched.  In 
addition, the ASCR has published, as a part of its new Strategy AV21 released in December 
2014, the overview of its so-called “application laboratories” in order to promote linkages 
to the industry. Yet the results of this measure remain to be seen. 
 
4.3 Knowledge markets 
Formal methods of intellectual property rights (IPRs) protection, in particular patents and 
their licensing, remain underutilized, as clearly shown by European Commission (2014), in 
spite of the continuous effort to improve the use of public R&D outputs in innovation 
processes and despite the fact that state of the art IPRs legislation is in place. Too few 
experts and little experience can be found in this domain, especially in the public sector, 
except only perhaps of a few exceptions under the umbrella of ASCR, such as the Institute 
of Organic Chemistry and Biochemistry (IOCB), that prove the rule. Poor commercialisation 
of R&D outcomes in general requires systematic attention as well as support to research 
excellence to produce high valuable research outcomes being worth of patenting costs. 
While statistics on applications to national patent office are not always comparable across 
countries, they can provide some indication of technological development activities that are 
not captured by EPO/PCT data. In the Czech Republic, according to the data by INCENTIM 
KU Leuven and Bocconi University (2014), 1.3 thousand patent applications were made at 
the EPO, 1.5 thousand patent applicants took the PCT route and the Industrial Property 
Office of the Czech Republic received about 8 thousand applications in the period 2000-
2010; these figures are based on fractional counting (). In terms of patenting per capita, 
however, the Czech Republic remains far below advanced countries.  
According to the survey of licenses by CZSO (2014a), between 2007 and 2013 the number 
of organizations with licensed patents nearly doubled from 40 to 73 and the number of 
licensing agreements on patents more than tripled from 155 to 472, respectively, hence 
there is a positie trend, despite the low levels. In 2013, public research organizations and 
universities had a share of 36.8% in national patent applications and 30% in the number 
of licensed patents but accounted for 85% of €88m income from licence fees from 
patents(, but a lion share of the latter can be traced back to income of a single 
organization, namely the IOCB, from licencing of patents for antiretroviral drugs developed 
by professor Antonín Holý to U.S. pharmaceutical companies. Hence, this is not a systemic 
feature. 
- 33 - 
 
As far as the policy in the area of IPRs is concerned, the owner of invention developed in 
the public sector, i.e. supported by institutional or project funding, is nominally the 
university or the government research institute and its utilization needs to be specified by 
their internal regulations. However, the oversight and enforcement of this rule is weak and 
there is a large scope for opportunistic behaviour of researchers when deciding on who 
owns IPRs on knowledge generated within public support. In practice, commercialization of 
inventions originating from the public sector follows both formal and informal rules 
established at the level of individual organizations, much depends on governance of the 
particular workplace, and hence there are wide differences in this respect throughout the 
system. National strategy of IPRs utilization is lacking.  
 
4.4 Knowledge transfer and open innovation 
Among the top objectives of the ongoing reform of the RDI system is to improve the 
commercialization of R&D outputs on the market for technology and innovation processes 
at large. Many support measures are in place to foster technology transfer and public-
private R&D cooperation with the aim to steer research towards practical outcomes. 
However, the linkages between public and private R&D sectors remain weak. In particular, 
there is a lack of supporting institutions (both formal and informal), a lack of qualified 
human resources for the technology transfer, unfavourable conditions for setting up 
academic spin-offs and insufficient supply of mediation services provided to innovative 
companies. 
ALFA, Competence Centres, DELTA and EPSILON support programmes recently launched (or 
under preparation) by the TA CR emphasize as one of their main goal promoting 
collaboration of enterprises with public research organisations. GAMA programme of TA CR 
with a budget of €69m over the period 2014 to 2019, the first call of which was launched 
and ten projects with a budget of €4.0m were selected for funding in 2014, is specifically 
designed to support the verification of R&D results in terms of their practical application 
and their subsequent commercial use. Many regional governments have implemented 
innovation voucher programmes in recent years, including the so far largest Inovační 
vouchery programme in the capital city of Prague with a budget of €0.5m in 2014; hence 
the resources devoted to this instrument have been very small so far. Since 2014 tax 
credits that enable enterprises to deduct R&D expenditures from their tax base have been 
extended to the purchase of external R&D services from research organisations. 
Nevertheless, there is strong evidence that technology transfer is limited. In 2013, 
privately-funded public R&D only amounted to €36m and 1.2% of GERD and only 3.3% of 
GERD financed by the business sector was performed by other organizations than the 
firms themselves (CZSO, 2014a),  which testifies to the weak link between the business 
sector and other parts of the innovation system. In fact, these proportions display a 
declining trend since 2000 and remained consistently low over 2008-2013. The share of 
public-private co-publications was about 1% compared to the EU28 average of 2.2% and 
remained below the EU28 levels in the vast majority of scientific fields over 2003-2013.  
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Private-public mobility of researchers appears to be weak. In 2012, about 7% of R&D 
employees in the business sector were doctorate holders (CZSO, 2014a), hence received 
research training in the university sector. Unfortunately, no direct data is available on the 
circulation between the private and public sectors, such as the share of researchers in 
public organisations with experience in the private sector and vice-versa. Other relevant 
information, including the share of professors whose primary occupation is in industry and 
the number of researchers benefiting from academia-industry exchange contracts, is 
probably not collected, because it is very close to zero. Also there is no official data on the 
number of invention disclosures, public-private research partnerships and start-ups 
stemming from public-private cooperation, because these events are fairly rare.  
Technology Transfer Offices (TTOs) are in infancy in the public sector. Currently, there are 
at least 15 TTOs, most of which have been established quite recently, though the number 
is growing with the increasing public support for their establishment. The majority of them 
operate within major universities (especially those oriented at technical and material 
sciences) or specialised intermediary organisations. Establishing technology transfer points 
and offices in research institutions as a way to use research results is one of the activities 
eligible within the Priority Axis 3 “Commercialisation and popularisation of R&D “ of the OP 
RDI administered by the MEYS. The first technology transfer offices were supported from 
this programme at the beginning of 2012. In addition, the MEYS supported the EF-TRANS 
project on “Efficient Transfer of Research and Development Outputs in Production and their 
Subsequent Utilization” with the goal to set up and bring into effect knowledge transfer 
between R&D institutions and industry. 
According to the Technological profile of the Czech Republic database developed by the 
AIE, there are 42 science and technology parks and 17 technological platforms. The 
Science and Technology Parks Association registers 10 accredited parks, 34 parks in the 
process of accreditation and 7 parks under preparation. CzechInvest provides a list of 13 
business incubators. Developing innovative clusters is supported by the programme 
COOPERATION-Technological platforms in the Priority Axis 5 “Environment for Enterprise 
and Innovation” of the OP EI administered by the MIT.  
 “Cooperation and knowledge transfer between academia and industry” is one of four 
priority areas of the National Innovation Strategy of the Czech Republic (NIS) that has been 
produced jointly by the MIT and MEYS in line with recommendations of the Innovation 
Union strategy of the EU in 2011. The NIS gives a rather dreadful account: “A very 
important mechanism of knowledge transfer is informal networks based on personal 
contacts. The problem is that collaboration happens between individuals and not between 
enterprises and research organisations, as the results of which research organisations 
suffer a loss of income. Moreover, these issues generate personal conflicts in research 
teams. For many researchers in the public sector, these informal linkages represent the 
main source of their personal income, which in turn limits the time they devote to science 
itself.” MIT (2011, pg. 7, translated by the author). 
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Generally speaking, the lack of rules, the inadequate enforcement of the existing ones, 
ineffective administrative processes, hence poor management of public-private linkages, 
creates fertile ground for opportunistic behaviour. Knowledge transfer incentives are 
usually set through internal payroll regulations and other internal regulations defining 
remuneration of researchers including extraordinary bonuses related to successful 
transfers, patents, licences etc. However, these practices differ by organisation, thus there 
are no generally accepted standards of behaviour. Systematic solution of the technology 
transfer issues at the national level, hence national knowledge transfer policy, is lacking.  
 
4.5 Innovation framework for SMEs 
TA CR has been established in 2009 as the dominant supporter of applied research and 
innovation and launched a portfolio of new programmes (most prominently ALFA, 
Competence Centres and the forthcoming EPSILON) but none of its programmes is 
specifically devoted to supporting innovation in SMEs. Several programmes of the OP EI 
under the MIT, namely Start, Development, Innovation, Progress and Guarantee, help start-
ups and SMEs enterprises to overcome the limited availability of external funding, while 
the Cooperation programme supports the establishment of technology platforms and 
clusters. INOSTART programme, a joint effort of the main commercial bank Česká 
spořitelna and the MIT that is backed by the Partnership Fund of Czech-Swiss Cooperation 
and the state-owned Czech-Moravian Guarantee and Development Bank, supports 
innovative business start-ups in terms of loan guarantees for innovative projects and 
consultancy services. Regional governments are increasingly implementing innovation 
voucher programmes, including in South Moravia, Moravia-Silesia and Prague. Hence, there 
is a small number of support programmes tailored particularly to the needs of innovative 
SMEs in place.  
 
4.6 Venture capital markets 
The European Commission (2014a) data indicates that the utilisation of venture capital to 
support innovative businesses and spin-off firms is one of the lowest among European 
countries and that the limited access to external sources of finance for innovation is 
perhaps the single most important obstacle to the improvement of the innovative 
performances. Unfortunately, a lack of experience among potential clients and rather 
traditional entrepreneurial culture do not form an environment favourable to venture 
capital expansion. Statistics on crowdfunding and business angels is not available, at least 
not reliable data from official sources, and there are no policy measures in place in this 
regard. Venture capital market is very small, only several projects are funded each year 
(for more details see Sections 2.5.1 and 2.5.3), which is probably why more nuanced 
information is not accessible. 
The MIT plan to launch a pilot project of a public-private seed fund supported from the OP 
EI has collapsed. The aim of the fund was to boost the grossly underdeveloped national 
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market for venture capital and support the creation of new knowledge-based companies, 
including university and research spin-offs. The pilot project was already presented at 15 
universities during the autumn of 2012 and four workshops for entrepreneurs in the spring 
of 2013. A budget of €53m was earmarked for this purpose. The seed fund was ready to 
start operation; however, the launch of the project has been derailed by the appeal of an 
unsuccessful candidate for the Fund’s custodian to the Office for the Protection of 
Competition (CzechTrade, 2014). In early 2014 the government decided to cancel the 
project. Nevertheless, there are plans to re-start this effort in the new programming period 
2014-2020. 
 
4.7 Innovative public procurement 
Generally speaking, public tenders, except of those for R&D, are very rarely recognised as 
the opportunity to promote innovation. Public procurement in R&D (assigned competitively) 
for the needs of public administration bodies is newly centralised under the BETA 
programme of the TA CR. A national target on public procurement of innovative goods and 
services has not been announced. The national procurement policy does not consider the 
objective of supporting innovation. 
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5. Performance of the National Research and Innovation 
System 
5.1 Performance of the National Research and Innovation 
system 
The Innovation Union Scoreboard 2014 (European Commission, 2014a) classified the 
Czech Republic among the “moderate innovators”, which maintain the overall innovative 
performance slightly below the EU28 average. Nevertheless, the Czech Republic moved up 
to the 2nd place in the moderate innovators category just short of Italy but already ahead 
of Spain, Portugal and Greece. Despite scoring below the EU28 average in most of the 
individual indicators under consideration, the Czech Republic is catching up with the 
category “innovation followers” in many important areas. In a nutshell, the Czech RDI 
system can be characterised by a combination of both moderate level and growth 
performance.  
The main strengths are in Human resources (youth with upper secondary education), Firm 
investment (non-R&D innovation expenditure) and Economic effects (sales share of 
innovations and contribution of medium and high-tech product exports to trade balance). 
The weak areas in which the Czech RDI system is far behind the EU28 average are 
concentrated in Open, excellent and attractive research systems (top scientific publications 
and non-EU doctorate students), Finance and support (venture capital) and Intellectual 
assets (patents, trademarks and designs). High growth has been detected in population 
with tertiary education, R&D expenditures, trademarks and designs, whereas the prime 
setback (from already a very low base) has been in venture capital. 
On average in 2012, the Czech Republic produced 15.97 publications per 10,000 
inhabitants, slightly the EU28 average (13.80), of which only 37.46% were internationally 
co-published, which is the sixth lowest share in the EU28. In 2012, the Czech Republic had 
about 598 international scientific co-publications per million population, which roughly 
corresponds to the level observed in other moderate innovators. In the period 2002-2012, 
a bit more than 7% of the Czech scientific publications were in the top 10% most cited 
publications worldwide in comparison with 11% of top scientific publications produced in 
the EU28 (ScienceMetrix, 2014).2 The share of public-private co-publications in the Czech 
Republic is 1.0% in the period 2008-2013 against 2.8% in the EU28.3 
According to the more detailed country profile (European Commission, 2014c), in particular 
the quality of scientific production and technological development, in other words the level 
                                              
2 These publication data are based on Elsevier's Scopus database. ScienceMetrix, Analysis and Regular 
Update of Bibliometric Indicators, study conducted for DG RTD. They represent an update of the data 
displayed in the table below. See also http://ec.europa.eu/research/innovation-union/index_en.cfm?pg=other-
studies 
3 Scival 2014, Scopus based publication indicators derived from Elsevier's SciVal platform, www.scival.com  
last accessed December 2014. 
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of excellence in S&T, is markedly behind than the EU28 average and is catching up only 
very slowly. Structure of the economy is generally favourable but business R&D investment 
is relatively low, despite a positive trend, thus the innovation performance is deemed to 
remain below its potential. Another evergreen weakness that is highlighted refers to the 
limited cooperation between the science and business sectors. The key science and 
technological strengths are identified in the fields of automobiles, other transport, 
construction, materials, energy and environment.  
 
Table 2: Assessment of the Performance of the National Research and Innovation System. 
1. ENABLERS Year CZ EU 
Human resources       
New doctorate graduates (ISCED 6) per 1000 population aged 25-34 2011 1.50 1.70 
Percentage population aged 30-34 having completed tertiary education 2012 25.60 35.80 
Open, excellent and attractive research systems       
International scientific co-publications per million population 2012 567.52 343.15 
Scientific publications among the top 10% most cited publications 
worldwide as % of total scientific publications of the country 
2009 5.61 10.95 
Finance and support       
R&D expenditure in the public sector as % of GDP 2012 0.87 0.75 
Venture capital (early stage, expansion and replacement) as % of GDP 2012 0.00 0.08 
2. FIRM ACTIVITIES       
R&D expenditure in the business sector as % of GDP 2012 1.01 1.31 
Linkages and entrepreneurship       
Public-private co-publications per million population 2011 33.75 52.84 
Intellectual assets       
PCT patent applications per billion GDP (in PPS€) 2010 0.70 3.92 
PCT patent applications in societal challenges per billion GDP (in PPS€) 
(climate change mitigation; health) 
2010 0.15 0.85 
3. OUTPUTS       
Economic effects       
Contribution of medium and high-tech product exports to trade balance 2012 3.79 1.27 
Knowledge-intensive services exports as % total service exports 2011 29.17 45.26 
License and patent revenues from abroad as % of GDP 2012 0.10 0.59 
Source: European Commission, IUS Database (2014). 
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5.2 Structural challenges of the national R&I system 
Many national assessments of the RDI system have been recently carried out in the 
context of the ongoing reform, notably the International Audit of Czech RDI summarized by 
Arnold (2011), the Update of the National Research, Development and Innovation Policy 
2009-2015 with an outlook to 2020 by CRDI (2013a) and the National RIS Strategy by 
MEYS (2014). Moreover, there are the twin documents the Competitiveness Report by the 
National Economic Council (2011) and the Strategy of International Competitiveness by 
MIT (2011a), including the follow-up National Innovation Strategy produced jointly by 
MEYS and MIT (2011b), which scrutinize the role of RDI in the broader policy context. 
Drawing on their findings, which are by and large in parlance with results of the Innovation 
Union Scoreboard assessments by the European Commission (2014ac) and with each 
other, the main structural challenges can be detected, not necessarily in the order of 
importance, in the following five areas. 
 
Governance, evaluation and research excellence 
Since 2008 the governance system is undergoing a profound reform outlined in the 
National RDI Policy of the Czech Republic 2009–2015 (CRDI, 2009) and the mid-term 
Update of the National Research, Development and Innovation Policy 2009-2015 with an 
outlook to 2020 (CRDI, 2013a). RDI funding system has been streamlined. TA CR has been 
established as the dominant provider of national support to applied research. The role of 
ministries has been gradually reduced, especially in favour of the CRDI, GA CR and TA CR. 
The CRDI has centralised principal activities, become effectively responsible for setting the 
entire national research budget and de facto assumed the role of a science ministry. 
However, the CRDI formally continues to be an advisory body of the government only; 
without adequate executive administration, analytical capabilities and budget line, which 
inhibits its capacity to make informed decisions on long-term strategy development. The 
CRDI has become overburdened with responsibilities, which it struggles to cope with given 
the limited resources.  
A particularly thorny liability of the CRDI, which haunts the policy debate for several years, 
is the dysfunctional evaluation methodology of research institutions, which determines the 
allocation of public institutional funding. The formulae-based approach that has been 
implemented early in the reform automatically reallocated the entire flow of institutional 
funding annually based exclusively on outputs generated in the preceding five years.  The 
idea was to make the allocation performance-based, which in turn was expected to reward 
quality, boost productivity and de-politicise the funding process. But the methodology has 
been resisted by the stakeholders and criticized as simply “not fit for the purpose” by 
Arnold (2011) for falling into the trap of reductionism, creating inherent instability of the 
funding flows, failing to address differences between fields of science, stimulating 
opportunistic behaviour and ignoring national thematic priorities.  
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As the result, the strategic policy-making has been complicated by arguments over the 
evaluation methodology. More recently, the institutional funding flow has been refined with 
the aim to address at least some of its flaws. In 2012, there was a short-term patch into 
the formulae that redirected the flows in a way agreed in political negotiations among the 
key stakeholders and that made the flows more stable. In 2013, a medium-term patch of 
the evaluation methodology, the so-called Metodika 2013 (CRDI, 2013b), has been 
introduced that awards bonuses for the best performing institutions and involves elements 
of international peer review, however, the evaluation methodology continues to heavily rely 
the formulae. In 2014, the MEYS signed under the IPN METODIKA project a contract with 
Technopolis Group to design a new system of evaluation of research organisations and 
allocation of institutional funding, which should be ready in May 2015. Nevertheless, a 
roadmap of its implementation has not been announced yet. This dispute locks the 
stakeholders in short-term focus and represents a major impediment for tackling many 
other problems that are intimately related to incentives laid down in the evaluation 
methodology.  
Political instability had a major negative impact on the RDI system in recent years, as there 
have been frequent changes of ministers, in particular in the MEYS, that made it difficult to 
implement consistent policy. All too often, the reform debates have been politicised and 
the decision making process dominated by interest groups, not based on strategic 
intelligence and dealing with the problems in a systematic manner. Many of the unresolved 
issues are symptoms of a lack of trust among the key actors, especially between the 
academia and industry on one hand and the stakeholders and the government on the other 
hand, which thwarts attempts to make deeper changes in the system. In 2014, the political 
framework seem to stabilize, but it remains to be seen whether the new majority 
government that took the office in early 2014 makes a tangible difference in governance 
of the RDI system.  
 
Stagnating public funding and new large infrastructures 
New large research centres and infrastructural projects with a total amount of subsidy of 
nearly €900m that are under construction and gradually opening with the support from the 
EU Structural Funds represent a great promise for boosting the national research output. 
However, the new projects represent a major funding puzzle, because the EU support is for 
the initial investment only. Later on, wage, maintenance and other operating expenses 
must be covered from other sources. So there is a danger that these projects turn from 
blessing to a curse for the public R&D system, as sizeable opportunity costs needs to be 
resolved. Many of these projects pledged when approved to obtain funding from private 
sources. But this seems to cover only a fraction of their needs and their operating costs 
start draining public R&D funding from the existing facilities. It is a major challenge for the 
RDI policy to integrate these new projects into the national system. 
In the meantime, national public R&D funding stagnates. Unless there is a breakthrough in 
the near future, unless the government noticeably expands outlays for R&D, public 
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research organisations, including the newly build projects, may end up being underfunded. 
According to preliminary estimates the full operating costs of the new research centres and 
infrastructures might amount from CZK 5b to 10b (€190m to 385m) per year (Rádio 
Impuls, 2013), which roughly represents as much as one fifth to one third of the current 
public R&D budget. Either the new projects or the existing infrastructure might need to 
shrink; possibly quite significantly. And in the final analysis this can have major disruptive 
impact for functioning of the national RDI system.  
Another critical bottleneck for success of the new large research centre and infrastructure 
projects is availability of qualified human resources, not to mention star scientists, on the 
labour market. Arguably, this can turn out to be a major problem, as the expected demand 
by far exceeds domestic supply in the relevant scientific fields. Some of the new staff will 
have to be poached from the existing infrastructure. Some of them, perhaps even their 
majority, will have to come from abroad. But attracting large numbers of top foreign 
researchers in a relatively short span of time required for launching the full operation of 
the projects is not going to be easy, if one considers the above mentioned funding 
uncertainties, the unresolved rigidities of national labour market for researchers, the 
lingering difficulties with attracting foreign talent and last but not least given the fact that 
the remuneration of scientist in the national system is far below the international 
competitive wage level.  
 
Skills shortages, rigid labour market for researchers and internationalization 
According to the assessment of MIT (2011b), because the reform of tertiary education 
remains uncompleted, there has been an unchecked expansion of university graduates, the 
quality of which is however hard to judge. Not much has changed in this respect in the 
meantime. The lack of highly skilled personnel is often cited as not only hampering the 
quality of research in public institutions but even more so as the major obstacle of 
innovation in the private sector. Yet modernization of the higher education system is long 
overdue, the higher education act has been amended seventeen times and it is broadly 
acknowledged that a comprehensive reform of the education system is necessary.  
Human resources management practices in the public sector need to be revised in order to 
reduce the widespread in-breeding, make career progression paths more transparent and 
intensify competition for posts. Horizontal mobility of academic staff is very limited. Arnold 
(2011) noted that management of research groups is underdeveloped, the groups tend to 
be very small, locked into existing research trajectories, lacking interdisciplinarity, there is 
little use of career development plansand only less than 10% of researchers are foreign, 
which is very small proportion by international standards. . An explicit internationalization 
strategy of the public research system is lacking. Since the higher education reform ended 
up in doldrums, these caveats remain as relevant as ever.  
Gender situation in research is unsatisfactory (NKC – ženy a věda, 2014). The share of 
female researchers (full-time equivalent) is very low, only 25% in FTE in 2013 and 
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decreasing in recent years (CZSO, 2014a), which is far below the EU28 average. Gender 
equality issues are almost entirely ignored in research policy, the testimony to which is the 
fact that there is very little, if anything, on this topic in the key strategic documents and 
there are no regulations or instruments in this regard in place. Overall, the approach to 
research human resource management in the public sector is unsystematic.  
 
Innovation capabilities, disembedded multinationals and venture capital 
Structurally, the business sector appears sound; the share of industries considered to be 
high- and medium-high-technology sector is relatively large, which represents a potential 
for upgrading. However, the business sector tends to specialize in low value added 
segments of value chains and competes predominantly on prices. Path-breaking innovation 
is rare; the economy is based on absorption of foreign technologies that are new to the 
firm or new to the country but not new to the world, as domestic sources of knowledge 
generation have not been yet established as the main driver of economic development. A 
major shift in policies during the reform has been from a system traditionally focused on 
science towards more attention devoted to boosting innovation. But the success has been 
at best partial so far.  
According to European Commission (2013a), only two Czech firms, both state-owned, 
feature amongst the world or EU top R&D investing firms, namely ČEZ (electricity) is 
1667th in top 2000 world and 453th in top 1000 EU R&D performers and České dráhy 
(transport) is 860th in top 1000 EU R&D performers. About 55% of business R&D was 
performed by foreign affiliates in 2013, which is a very high proportion in international 
standards. As noted by MIT (2011b), foreign affiliates are largely doing low-added value 
work, even within high-tech industries, as the parent companies tend to keep the core 
research activities close to their headquarters abroad. A major policy challenge is how to 
make the multinationals more embedded in the national innovation system and how to 
motive them to upgrade the activities perform locally.  
Limited access to external private sources of finance for innovation is perhaps the single 
most important obstacle for improving the innovative performance, particularly in the 
sector of SMEs. Availability of venture capital to support innovative businesses and spin-off 
firms trying to commercialize research outcomes is well-known to be extremely low; one of 
the lowest among European countries. A lack of experience among potential clients and 
rather traditional entrepreneurial culture do not constitute a favourable environment to 
venture capital expansion. No tax measures supporting venture capital or business angels 
are in place. 
 
Underdeveloped public-private collaboration, technology transfer and market for 
technology 
Given the historical separation of science and business and the prevailing differences in 
culture or attitudes in these spheres, the lack of collaboration between them is one of the 
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main policy issues. Despite steady effort to strengthen public-private linkages, deficiencies 
are present on both sides, namely limited industry-valuable results and poor technology 
transfer practices in the public sector on one hand and low absorptive capacity of public 
research outputs in companies on the other hand. Since the business sector tends to lag 
behind the technology frontier, except perhaps of the dis-embedded multinationals, most 
of the firms focus on absorbing existing technologies rather than collaborating with 
science. Poor horizontal mobility of professionals between the sectors and sometime too 
rigid setting of support measures reinforce the weaknesses. National governance strategy 
of public-private collaboration and technology transfer is lacking. 
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Table 3: Policy measures addressing structural challenges in the Czech Republic. 
Challenges  Policy measures/actions 
addressing the challenge 
Assessment in terms of 
appropriateness, efficiency and 
effectiveness 
1. Governance, evaluation 
and research excellence 
CRDI became the central RDI 
policy actor 
Public R&D funding is 
streamlined 
Share of competitive funding 
increased 
TA CR takes over support for 
applied R&D and innovation 
Evaluation of research 
institutions patched 
More complex evaluation in the 
making 
CRDI does not have sufficient 
administrative and analytical capacity to 
deliver 
Evaluation method of research 
organisations is ineffective is stimulating 
research excellence 
Most institutional funding continues to 
flow through the old mechanistic 
formulae 
Progress in putting forward more complex 
evaluation methodology has been very 
slow 
2. Stagnating public 
funding and new large 
infrastructures 
Public R&D funding stagnates 
Large research infrastructures 
constructed 
National program sustainability I 
is launched 
Public R&D needs to increase to meet the 
challenges 
Long-term funding of large research 
infrastructures not secured 
Staffing of the large research 
infrastructures is problematic 
 
3. Skills shortages, rigid 
labour market and 
internationalization 
Higher education reform in 
doldrums 
Česká hlava awards 
Otevřená věda I. and II. 
popularization programmes 
NÁVRAT brain gain programme  
Scientific Visa Package 
Higher education reform is overdue for a 
long time 
In-breeding is widespread in higher 
education 
Competition for posts is not transparent 
and generally limited 
Early career opportunities remain scarce 
Gender inequality problems are ignored  
Internalization is very low 
4. Innovation capabilities, 
disembedded 
multinationals and venture 
capital 
TA CR launched a portfolio of 
new support programmes 
R&D tax refunds 
Investment incentives for 
establishing R&D centres 
Commitment to support upgrading of 
innovation capabilities 
Shifting emphasis from direct subsidies 
to indirect support of business R&D 
Evaluation of innovation policy remains 
poor 
Attempts to kick-start the venture capital 
market have not been successful so far 
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Challenges  Policy measures/actions 
addressing the challenge 
Assessment in terms of 
appropriateness, efficiency and 
effectiveness 
5. Underdeveloped public-
private collaboration, 
technology transfer and 
market for technology 
TA CR programmes stimulate 
joint public-private projects and 
commercialization 
Support for technology transfer 
services, management of IPRs, 
etc. 
R&D tax refunds extended to 
contract research 
Much greater emphasis on public-private 
collaboration in new programmes 
Governance of technology transfer in 
research organisation remains poor 
National governance framework is lacking 
 
5.3 Meeting structural challenges 
National RDI Policy of the Czech Republic 2009–2015 (CRDI, 2009) is the central policy 
document, which has been developed to facilitate the implementation of the Reform of the 
RDI system in the Czech Republic (CRDI, 2008a). More recently, the Update of the National 
Research, Development and Innovation Policy 2009-2015 with an outlook to 2020 (CRDI, 
2013a) has brought the reform agenda into line with the medium-term plans of public 
R&D spending, the growth of which has been significantly downsized due to the economic 
crisis, but otherwise confirmed the reform track. 
 
The main objectives of the updated national RDI policy are fourfold:   
 To stimulate research excellence, use of new knowledge and aligning the 
allocation of public funding to these ends; 
 To utilize R&D outputs in innovations, improve public-private cooperation in 
RDI and conditions for efficient diffusion and use of knowledge; 
 To develop human resources, promote mobility of researchers and prevent 
brain drain abroad; 
 To facilitate development/sustainability of new research centres and 
infrastructures, their cooperation with each other and with the application 
sphere;  
 
New R&D programmes are supposed to follow the updated National Priorities of Oriented 
Research, Experimental Development and Innovation (CRDI, 2012) that have been 
summarized under six long-term thematic focus areas:  
 Competitive knowledge-based economy 
 Sustainable energy and material resources 
 Environment for quality life 
 Social and cultural challenges 
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 Healthy population 
 Safe society 
 
The priorities are designed to reflect major societal challenges and needs of the society as 
concrete goals solvable through RDI in available capacities and are set for the time horizon 
until 2030. The new priorities should be taken into account in the multi-annual R&D budget 
plans and respected in designing public RDI support, including prospectively in allocation of 
institutional funding.  
The National RIS Strategy identified eight key enabling technologies: i) Advanced materials; 
ii) Nanotechnology; iii) Micro- and nano-electronics; iv) Advanced production technologies; 
v) Photonics; vi) Industrial biotechnology; vii) Knowledge for digital economy, cultural and 
creative industries; viii) Social science knowledge base for non-technical innovation, which 
are broadly in line with the long-term thematic priorities, and there are four national S3 
platforms: i) Engineering; ii) Information and telecommunication services and software; iii) 
Transport equipment; and iv) Pharmaceuticals and life technologies (MEYS, 2014).  
The Government adopted a comprehensive long-term Strategy of International 
Competitiveness in 2011 (MIT, 2011a), which addressed framework conditions affecting 
innovation performance in a broad sense. The core of the competitiveness strategy called 
“3i” deals with institutions, infrastructure and innovation; the three pillars that are indicated 
as the main weaknesses of the current system. In parallel, the National Innovation Strategy 
(MIT, 2011b) that was produced jointly by the MEYS and the MIT develops in more 
comprehensive way the innovation pillar. The strategy outlines a long list of concrete goals 
for innovation policy summarized under four main priority axes: 
 Improving conditions for excellent research 
o Efficient public R&D spending 
o Access to state-of-the-art infrastructure 
o Leveraging ERA participation 
 Developing cooperation for transfer of knowledge between business and 
academia  
o Governance of PROs geared for technology transfer 
o Extending support for public-private cooperation 
o Deepening innovation infrastructure at the regional level 
 Promoting innovative entrepreneurship 
o Providing access to high-quality consultancy services 
o Developing venture capital market 
o Targeting investment incentives for research activities 
o New instruments for export promotion 
o Technological foresight as the source of strategic intelligence 
o Public procurement and regulation with innovation in mind 
 Skilled human resources for innovation 
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o Higher education reform necessary for boosting quality 
o More support for lifelong learning 
o Core competencies and skills for innovation in curriculum 
o Attracting talent from abroad 
 
Evolution and analysis of the policy mix 
One aim that has been repeatedly stressed is promoting excellence in research. Yet this 
has been grossly mismanaged by introducing the formulae-based system of evaluation of 
research institutions, regardless of other concerns. Arnold (2011) recommended that the 
evaluation practice should be the subject of root and branch reform, refocusing on 
outcomes and impacts in addition to outputs. The latest modification of the evaluation 
methodology, the so-called Metodika 2013 (CRDI, 2013b), established two new pillars that 
involve international peer review and bonuses for research excellence; however, the 
formulae-based pillar remains dominant. IPN METODIKA project launched under the 
auspice of MEYS is preparing a new more complex evaluation methodology, which should 
be ready during 2015.  
Another closely related challenge is to secure funding for operation of the newly 
constructed research centre and infrastructure projects, which is likely to send ripples 
throughout the public research sector. To secure immediate funding the MEYS has 
launched the National program sustainability I. and the prospective National program 
sustainability II. that is going to support at least the start of their operation. Nevertheless, 
the induced pressures in allocation of institutional funding and the broader picture of their 
integration into the national system remains a challenge. Overall, national public R&D 
funding has stagnated in recent years in the context of the economic crisis but needs to 
start increasing again in order to tackle the funding problems and to safeguard meeting 
the national target of 1% of GDP flagged in Europe 2020 initiative. 
Unfortunately, reform of the labour market for researchers that was in preparation for 
three years ended up in doldrums. The higher education reform initially involved bold plans 
for modernization of conditions for human resources development. The reform was 
supposed to be implemented already but the drafting process has been derailed due to 
instability of the government and disagreements among the stakeholders The push for 
enacting a new law has been first relegated to an amendment that has been delayed by 
the collapse of the centre-right government in mid-2013 and then watered down 
significantly. The amendment is a compromise with the existing establishment that falls 
short of expectations if compared to the ambitious aims of the reform agenda. For 
instance, the new regulation is not expected to alter the current system of recruitment, 
hence not tackling the problem of inbreeding.    
In recent years, the government has started to be much more active in promoting 
cooperation of private and public bodies in R&D. A number of new measures were 
introduced that are shifting the focus of innovation policy from supporting internal RDI in 
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firms to leverage public subsidies for the purpose of stimulating public-private 
collaboration and commercialization of research results. At the forefront of this 
transformation is the wave of new programmes designed and implemented by the TA CR, 
which support applied research, collaboration between research and application spheres 
and transfer of knowledge: 
 
 ALFA supports projects of applied research and experimental development and 
stimulates intensity and effectiveness of R&D cooperation between businesses and 
research organisations; 
 BETA is a programme of public procurement in RDI for the needs of public 
administration bodies;  
 OMEGA supports research in applied social sciences; 
 Competence Centres funds creation and operation of RDI centres for progressive 
fields with strong application potential and a perspective for significant 
contributions to competitiveness;  
 GAMA supports the verification of R&D results in terms of their practical application 
and their subsequent commercial use; 
 DELTA provides applied research grants for joint international projects with third 
countries. 
 EPSILON is aimed at supporting applied research and experimental development 
with a high potential for rapid application in innovations in a selected the priority 
areas. 
 
Attention to support of RDI in industrial enterprises from start-ups to mature enterprises 
and fostering public-private linkages is paid in the programmes administered by the MIT 
and financed either from the OP EI (the sub-programmes called Innovation, Potential, 
Cooperation and ICT and Strategic Services) or from the national sources (TIP). The OP RDI 
administered by the MEYS also includes several research and academia-industry links 
funding measures, which include support of commercialisation of R&D outputs in research 
institutions, financing research up to the stage of the subsequent commercial use (proof of 
concept stage) and support of intellectual ownership protection. Several regional 
governments have started innovation voucher programmes since 2012, which represents a 
much needed early step to regionalization of innovation policy, but the amount of funding 
channelled through this route is very limited. 
Since 2005 the Ministry of Finance (MF) operates a system of tax incentives that allows 
firms to deduct expenditures on R&D carried out in-house from their tax base. It has been 
recognized, however, that this form of tax deduction is going against the need to intensify 
collaboration between the business sector and academia. Hence, starting from 2014 the 
indirect fiscal support through R&D tax credits was extended to the purchase of external 
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R&D services from research organizations with the aim to stimulate public-private 
linkages. Access to venture capital continues to be problematic.  
 
Assessment of the policy mix 
Generally speaking, the national policy mix attempts to tackle the major structural 
challenges, however, is some areas the outcome falls short of expectations. A lot of 
attention has been devoted in the RDI reform agenda to making the national research 
system more effective; leaving the dysfunctional mechanism for allocating institutional 
funding aside, a noticeable progress has been made in streamlining the funding system, 
increasing the share of public funding allocated on a competitive basis and pinpointing 
sensible thematic research priorities.  
The CRDI that has assumed a central role in the new governance system needs to be 
provided with resources that allow it to live up to this task. The GA CR and TA CR that have 
become responsible for competitive funding need to be further supported to mitigate the 
fragmentation of support programs. Several large research infrastructural projects, 
including pan-European infrastructures, are opening or under construction, which, if their 
funding is secured, have a potential to both open new avenues for international co-
operation and make the system more competitive. Much remains to be done in improving 
labour market for researchers and in fostering gender equality in research, particularly as 
far as limited mobility, internationalization, early career opportunities, rigid recruitment 
practices and widespread in-breeding are concerned. 
The inadequate evaluation methodology of research institutions results inter alia in the 
insufficient quality of R&D results and the detachment of public research from industrial 
and societal needs. More generally, standards of evaluation remain fairly low and this in 
turn appears to be a rather understated problem. Present evaluations of research 
programmes tend to be highly descriptive, including only quantitative formulation of the 
results achieved, which rarely provide strategic intelligence insights for policy makers. 
Assessment with regards to development of relevant science fields, industry sectors or 
grasping societal needs, not mentioning counterfactual analysis, is not conducted. 
Systematic evaluation of research organisations is missing.  
Major challenges remain to be tackled in the domain of circulation, access and transfer of 
scientific knowledge, which has been historically a weak aspect of the system. More 
intensive inclusion of the private sector in joint public-private research projects seems to 
be promising, such as, for instance in the new programmes that have been introduced by 
the TA CR, though evidence on their effectiveness is not available yet. Despite these 
measures for the public-private interface, the commercialization of publicly funded 
research into innovative solutions in the business sector remains a constant challenge. IPRs 
continue to be grossly underused.  
A major policy shift that needs to be applauded has been from a system traditionally 
based on direct public subsidies to RDI in the business sector towards introducing much 
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wider portfolio of measures aimed at alleviating the problem of insufficient availability of 
funding for private R&D efforts, such as the R&D tax credits, loans, guarantees and 
venture capital; which target the type of applicants, including small and new firms, that 
typically do not use the direct support. More measures that go beyond the direct subsidies 
are clearly desirable in the future.  
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Annex 2 - Abbreviations 
 
Abbreviation English Czech 
ASCR Academy of Sciences of the Czech Republic Akademie věd ČR 
AIE Association of Innovative Entrepreneurship Asociace inovačního podnikání ČR 
AVO Association of Research Organizations Asociace výzkumných organizací 
BERD Business Expenditure on Research and 
Development 
Výdaje na výzkum a vývoj 
v podnikatelském sektoru 
CERN European Organisation for Nuclear Research Evropská organizace pro jaderný 
výzkum 
COST European Cooperation in Scientific and Technical 
Research 
Evropská spolupráce ve vědeckém a 
technickém výzkumu 
CRDI Council for Research, Development and 
Innovation  
Rada pro výzkum, vývoj a inovace 
CZK Czech koruna Česká koruna 
CZSO Czech Statistical Office Český statistický úřad 
ELI Extreme Light Infrastructure  Extreme Light Infrastructure 
ERA European Research Area Evropský výzkumný prostor 
ERDF European Regional Development Fund Evropský fond pro regionální rozvoj 
ESF European  Social Fund Evropský sociální fond 
ESFRI European Strategy Forum on Research 
Infrastructures 
European Strategy Forum on Research 
Infrastructures 
ESIF European Structural and Investment Funds Evropské strukturální a investiční 
fondy 
ESO European Southern Observatory  Evropská jižní observatoř 
EU European Union Evropská unie 
EU28 European Union including 28 Member States Evropská unie s 28 členy 
FP European Framework Programme for Research 
and Technology Development 
Evropský rámcový program pro 
výzkum a vývoj 
FP7 7th Framework Programme 7. rámcový program pro výzkum a 
technologický rozvoj 
GA CR Czech Science Foundation Grantová agentury ČR 
GBAORD Government Budget Appropriations or Outlays on 
R&D 
Státní rozpočtové výdaje a dotace na 
výzkum a vývoj 
GDP Gross Domestic Product Hrubý domácí product 
GERD Gross Domestic Expenditure on R&D Celkové výdaje na výzkum a vývoj 
HEI Higher education institutions Vysokoškolský sektor 
ICT Information and Communication Technologies Informační a telekomunikační 
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technologie 
IOCB Institute of Organic Chemistry and Biochemistry 
of ASCR 
Ústav organické chemie a biochemie 
AV ČR, v.v.i. 
IPO Industrial Property Office of the Czech Republic Úřad průmyslového vlastnictví 
IPR Intellectual Property Rights Práva duševního vlastnictví 
MEYS Ministry of Education, Youth and Sports of the 
Czech Republic 
Ministerstvo školství, mládeže a 
tělovýchovy ČR 
MIT Ministry of Industry and Trade of the Czech 
Republic 
Ministerstvo průmyslu a obchodu ČR 
MRD Ministry of Regional Development of the Czech 
Republic 
Ministerstvo pro místní rozvoj ČR 
MoLSA Ministry of Labour and Social Affairs of the 
Czech Republic 
Ministerstvo práce a sociálních věcí ČR 
NABS Nomenclature for the Analysis and Comparison 
of Scientific Programmes and Budgets 
Nomenklatura pro analýzu a srovnání 
vědeckých programů a rozpočtů 
NIS National Innovation Strategy Národní inovační strategie 
OP Operational Programme Operační program 
OP EI Operational Programme Enterprise and 
Innovation 
Operační program Podnikání a inovace 
OP PIK Operational Programme Enterprise and 
Innovation for Competitiveness 
Operační program Podnikání a inovace 
pro konkurenceschopnost 
OP PGP Operational Programme Prague – Growth Pole of 
the Czech Republic 
Operační program Praha – pól růstu 
ČR 
OP RDI Operational Programme Research and 
Development for Innovation 
Operační program Výzkum a vývoj pro 
inovace 
OP VVV Operational Programme Research, Development 
and Education 
Operační program Výzkum, vývoj a 
vzdělávání 
PROs Public Research Organisations Veřejné výzkumné organizace 
R&D Research and development Výzkum a vývoj 
RDI Research, Development and Innovation Výzkum, vývoj a inovace 
RIs Research Infrastructures Výzkumné infrastruktury 
RIS3 Research and Innovation Strategy on Smart 
Specialisation 
Strategie inteligentní specializace 
S&T Science and Technology Věda a technologie 
TA CR Technology Agency of the Czech Republic Technologická agentura ČR 
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